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Abstract
Cellular survival and homeostasis is achieved due to the complex network o f proteins
present within cells to regulate responses to external stimuli. The phosphatidylinositol3’-OH kinase (PI3’K) and the Wnt/Wg pathways, incorporate many important effector
molecules and regulatory proteins to govern such cellular events as survival, apoptosis,
cell-cell communication and fate determination. Protein kinase B (PKB) and glycogen
synthase kinase-3 (GSK-3)/Shaggy are the main effector molecules in the PI3’K and
Wnt/Wg pathways respectively, and rely on interactions with numerous regulatory
proteins for initial phosphorylation or dephosphorylation, and subsequent activation.
Integrin linked kinase (ILK) has been shown to act upstream o f both PKB and GSK3/Shaggy in mammalian systems, and regulates them in a PI3’K dependent manner and
has been postulated as a PI3’K dependent protein kinase-2 (PDK-2) molecule. Studies
with Drosophila ILK (DILK) further validate this idea. In the present study, it is shown
that DILK is 59% similar to human ILK and is regulated in a PI3’K dependent manner
in vivo. DILK is able to phosphorylate PKB in vitro and this occurs at serine-505
residue, the Drosophila homologue to mammalian serine-473, in vivo. DILK was also
shown to phosphorylate Shaggy, the GSK-3 homologue, in vitro. In addition, it was
illustrated that insulin and wortmannin, PI3’K specific activator and inhibitor
respectively, affect various genes at the nuclear level. Using microarray technology,
insulin and wortmannin were shown to regulate the expression o f 1151 genes, o f which
two were chosen for further verification by RT-PCR. Dream was verified to be upregulated by insulin and the functional significance o f this effect still remains to be
determined.
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CHAPTER ONE
GENERAL INTRODUCTION

Chapter Summary
Signal transduction pathways are very important cellular processes and are responsible
for the survival and overall functioning o f living cells. Complexity within cells is
increased due to the numerous signaling pathways that cope with environmentally
induced changes, and disruption o f these pathways can lead to adverse outcomes for the
cell. Two distinct pathways, the phosphatidylinositol-3’-OH kinase (PI3’K) and the
Wnt/Wg pathway, regulate cell survival, growth, apoptosis and fate determination.
There are many components o f each pathway that are responsible for the transmission of
the external signal to the interior o f the cell, resulting in a cellular response that may
include changes in cell physiology and morphology. These effector molecules must
interact properly and efficiently to ensure the correct transmission o f the desired signal.
Integrin linked kinase (ILK) is an important mediator o f the PI3’K and Wnt/Wg
pathways, and its complete characterization in Drosophila will aid in the understanding
o f how it functions. Many technologies are in place that allow for the characterization
o f cellular components and determination o f cell function. Microarrays, a relatively new
technology, have advanced gene studies to open a whole new world o f information
previously unattainable with studies involving single gene analysis.

INTRODUCTION
The survival and fate o f a cell depends on the intricate functioning o f numerous
components within the cell that respond to external stimuli. The interplay between these

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

components regulates various cellular processes. Signal transduction pathways are
responsible for the transduction o f external stimuli to the interior o f the cell. Activation
of these pathways can be initiated by binding o f a ligand, such as growth factors, to their
respective receptors, or by the interaction o f the cell with the extracellular matrix (ECM).
Subsequent events translocate effector molecules to the membrane leading to the
phosphorylation or dephosphorylation o f target proteins. The phosphatidylinositol-3’OH kinase (PI3’K) and the Wnt/Wg pathways are two signal transduction pathways that
regulate important cellular events such as survival, growth, apoptosis and fate
determination. Attached to the integrin receptors in the plasma membrane, integrin
linked kinase (ILK) has been shown to act upstream o f both main effector molecules in
these pathways.

The PI3’K Pathway
Regulation o f the PI3’K pathway is governed by numerous kinases and phosphatases.
The balance between the two maintains proper regulation o f cellular processes. Protein
kinase B (PKB), the main effector molecule o f this pathway, is regulated by ILK.
Initiation o f the pathway in response to stimuli, such as insulin, results in activation
through the initial phosphorylation o f phosphatidylinositol 3-kinase (PI3’kinase), which
is a known receptor proximal intracellular effector (Downward, 1997, and King et al.,
1997). PI3’kinases can be classified as class I, class II or class III, based on their
substrate specificity in vitro. Studies with this kinase, including knock out and
transgenic models in numerous organisms, have advanced our knowledge o f the
mechanism o f PI3 ’K signaling. This signal can be turned off by the tumour suppressor

2
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gene, phosphatase and tensin (PTEN), a phosphatidylinositol phosphatase, which is able
to remove the phosphate from the 3’ position of the inositol ring in Ptdlns (3, 4, 5)P 3
(Maehama and Dixon, 1998, Myers et al., 1998, Stambolic et al., 1998). In addition,
mutated platelet derived growth factor (PDGF) receptors that are unable to activate
P D ’kinase are also unable to activate PKB (Burgering and Coffer, 1995, Franke et al.,
1995). Dominant negative P D ’kinase prevents the PDGF and insulin induced activation
of PKB (Burgering and Coffer, 1995, Andjelkovic et al., 1996, Andjelkovic et al., 1997)
and constitutively active forms o f P D ’kinase are able to activate PKB (Didichenko et al.,
1996, R eif et al., 1997, Klippel et al., 1997). In Drosophila, it has been shown that flies
possess three classes o f PI3’kinases, one which is homologous to mammalian p i 10, one
which is homologous to mammalian Vps34p and a novel P D ’kinase (MacDougall et al.,
1995). Class 1A P D ’kinase, homologous to mammalian p i 10 and referred to as D pi 10,
is associated with a src-homology 2 (SH2) containing adapter p60, which is similar to
the adaptor p85 in mammalian systems, but lacks the N-terminal src-homology 3 (SH3)
domain and Philadelphia chromosome breakpoint cluster region gene product (BCR)
domain (Weinkove et al., 1997). However, similar to mammalian systems, p60
recognizes pYXXM (pY represents phosphotyrosine, M represents methionine and X
can be any residue) motifs in receptor tyrosine kinases (RTKs) and associated substrates
that also contain the pYXXM m otif (Weinkove et al., 1997). Therefore, it is likely that
Dpi 10 would act downstream o f the Drosophila insulin receptor homologue, inr/dir
(Fernandez et al., 1995, Ruan et al., 1995). This insulin receptor homologue contains a
C-terminal extension with pYXXM motifs that have been shown to interact directly with
P D ’kinase when artificially joined to the human insulin receptor (Yenush et al., 1996).

3
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Interestingly, there was weak loss o f function in Drosophila due to mutations in the inr
receptor that affected growth and reduced cell numbers (Chen et al., 1996). Studies with
mammalian PI3’kinases have determined that class IP I3 ’kinases are heterodimers of
approximately 200 kDa that phosphorylate phosphoinositide (Ptdlns), Ptdlns 4-P and
Ptdlns (4 ,5 )P 2 in vitro, and preferentially phosphorylate PtdIns( 4 , 5 )P 2 in vivo (Stephens
et al., 1991, Hawkins et al., 1992 reviewed in Wymann and Pirola, 1998). Activation of
this class o f PI3’kinases is due to several factors including extracellular signaling via
membrane receptors that exhibit intrinsic protein tyrosine kinase activity, receptors that
are coupled to src-like protein tyrosine kinases or receptors linked to G proteins. O f
these three possible methods o f activation, the activation o f membrane receptors that
exhibit intrinsic protein tyrosine kinase activity relates to the PI3’K signaling pathway.
Class I P D ’kinase is inactive in quiescent cells, and upon activation by extracellular
agonists such as insulin or platelet derived growth factor (PDGF), is translocated to the
plasma membrane where it is activated, and subsequently increases the formation of
secondary lipid products, such as Ptdlns ( 3 ,4 ,5)P 3 (PIP 3). This increase in secondary
lipid products provides adequate resources for downstream molecular targets such as
PKB/Akt. Protein kinase B is translocated to the membrane and activated upon
interaction with phosphoinositides. Both Ptdlns (3, 4, 5)P 3 and Ptdlns (3, 4 )P 2 can act as
second messengers and recruit various proteins to the membrane (Toker and Cantley,
(1997). PKB/Akt binds to the phosphoinositides PIP 3 and PIP 2 (3, 4) via its pleckstrin
homology (PH) domain.

4
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PH domains are approximately 100 amino acids long and have been identified in many
organisms, including Drosophila (Shaw, 1996, Rebecchi and Scarlata, 1998). When the
PH domain o f PKB is mutated, it is unable to be activated by PIP 2 through stimulation of
the cell by PDGF (Franke et al., 1995, Franke et al., 1997), indicating that the PH
domain is very important for PKB activation. It was shown that translocation o f PKB to
the plasma membrane by insulin growth factor-1 (IGF-1) requires the PH domain, and
could be negated by wortmannin, a P D ’kinase specific inhibitor (Andjelkovic et al.,
1997). Once PKB is targeted to the membrane, it is active (Andjelkovic et al., 1997).
The crystal structure for the PH domain of PKB bound to PIP 3 was recently determined
and reiterates equal affinity for binding o f PKB to PIP 2 and PIP 3 (Thomas et al., 2002).

Protein Kinase B (PKB)
Structure and Topography
Protein kinase B, also commonly referred to as Akt, is the major effector molecule o f the
PI3’K pathway and is activated by numerous growth and cell survival factors such as
PDGF, insulin, cytokines and serum (reviewed in Galetic et al., 1999, Andjelkovic et al.,
2000, Chan et al., 1999, Datta et al., 1999, Kandel and Hay, 1999, Scheid and Woodgett,
2001). PKB/Akt was originally identified from an oncogene, v-akt, found in a
lymphoma characteristic o f rodent T-cells (Bellacosa et al., 1991). PKB is a
serine/threonine protein kinase and belongs to the AGC or second messenger subfamily
(Jones et al., 1991a; Jones et al., 1991b). The initial identification o f two ubiquitously
expressed iso forms o f PKB, a and P, introduced a new sub-family o f second messenger
related kinases (Jones et al., 1991a and b, Coffer and Woodgett, 1991). A third isoform,

5
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PKBy, was later cloned from a rat cDNA library (Konishi et al., 1995). However, all
PKB isoforms share a PH domain N-terminal to the catalytic domain followed by the Cterminal regulatory domain or hydrophobic m otif (HM) (Haslam et al., 1993, Ingley and
Hemmings, 1994). The HM regulatory domain provides a docking site for PI3’K
dependent kinase-1 (PDK-1) (Balendran et al., 2000, Frodin et al., 2002, Biondi et al.,
2001) as well as allosteric regulation o f catalytic activity (Frodin et al., 2002). Stability
is ensued by association with hydrophobic and phosphate binding pockets in the kinase
domain. This pocket is referred to as the PKC related kinase-2 (PRK2)-interacting
fragment (PIF)-pocket due to its initial determination as the HM binding site o f protein
kinase PRK2 called PIF (Balendran et al., 1999). Together, these three domains form a
phosphoprotein o f approximately 56 kDa that has been conserved throughout evolution
from Caenorhabditis elegans through Drosophila to mammals. The consensus sequence
for the PKB phosphorylation site was determined to be Arg-X-Arg-Y-Z-Ser/Thr-Hyd,
where X can be any amino acid, Y and Z are small residues other than glycine and Hyd
represents a bulky hydrophobic residue (Alessi et al., 1996b). This consensus sequence
is found in a variety o f substrates allowing PKB to have many physiological functions
and phosphorylate numerous downstream targets, including transcription factors.

PKB Functions
Protein kinase B was first identified as having a role in insulin signaling in Dr. Cohen’s
lab, and was shown to inactivate GSK-3 (Cross et al., 1995). PKB negatively regulates
serine-21 in GSK-3a and serine-9 in GSK-3P, in a PI3’K dependent manner. The
inhibition o f GSK-3 paralleled with the activation o f glycogen synthase phosphatase

6
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accounts for the stimulation o f glycogen synthase resulting in glycogen synthesis in
skeletal muscle and L 6 myotubules (Cross et al., 1995).

Protein kinase B also plays a major role in cell survival and inhibition o f apoptosis.
Upstream o f PKB, PI3’kinase was initially implicated in the suppression o f apoptosis
(Yao and Cooper, 1995). It has been shown that PKB blocks apoptosis induced by
various apoptotic stimuli, which may include i) removal o f growth factors, ii) UV
irradiation, iii) detachment o f cells from the ECM, iv) cell cycle arrest, or v) DNA
damage (reviewed in Chan et al., 1999, Datta et al., 1999, Kandel and Hay, 1999).
Subsequently, it was determined that PKB could also regulate cell survival.

Constitutively active PKB was found to promote cell survival in the absence o f a
stimulant and by inhibiting cell death machinery (Dudek et al., 1997). In eukaryotes,
some members o f the BCL-2 family o f proteins regulate cell survival while others
regulate cell death (Datta et al., 1999). BAD is a BCL-2 family protein that regulates
cell death and is a direct target for PKB/Akt, which phosphorylates and inactivates this
pro-apoptotic factor (Datta et al., 1997, del Peso et al., 1997). Other substrates that
mediate cell death including the protease, caspase 9 (Cardone et al., 1998), the Forkhead
family o f transcription factors (Biggs et al., 1999, Brunet et al., 1999, Kops et al., 1999,
Rena et al., 1999, Tang et al., 1999), and the N F - kB regulator kinase (Kane et al., 1999,
Khwaja, 1999, Ozes et al., 1999, Romashkova and Makarov, 1999) are also direct
substrates for PKB phosphorylation.

7
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Furthermore, the ability o f PKB to regulate cell growth is o f extreme importance with
respect to tumourgenesis. The finding that the oncogene from the AKT 8 retrovirus
corresponds to the murine form o f PKBa (c-Akt) fused to the viral gag protein was a
dramatic discovery (Bellacosa et al., 1991). Fusion with the gag protein introduces an
N-terminal myristic acid that allows PKB to translocate to the plasma membrane
(Ahmed et al., 1993). It was later identified that this event was sufficient for the
complete activation o f PKB by phosphorylation on both threonine and serine residues
resulting in constitutive activation (Andjelkovic et al., 1997). Constitutively active
forms o f PKB help to explain the oncogenic potential o f v-Akt, a chimera o f viral gag
protein and PKB. The N-terminal myristic acid group o f v-Akt alters the subcellular
localization and consequently renders the kinase constitutively active (Andjelkovic et al.,
1997, Ahmed et al., 1993). Constitutive activation eliminates the normal course of
events usually required for PKB activation.

The discovery that the catalytic subunit o f PI3 ’kinase has oncogenic potential has also
reiterated the oncogenic nature o f the PI3’K/PKB pathway (Chang et al., 1997), as well
as the fact that PTEN, a major tumour suppressor gene, is an upstream negative
regulator o f PKB (Maehama and Dixon, 1998, Myers et al., 1998, Stambolic et al.,
1998). Initially PTEN was not recognized as a negative regulator o f the PI3’K pathway
and PKB. It was isolated as a tumour suppressor gene that was mutated in many forms
o f cancer, which was thought to encode a dual specificity tyrosine phosphatase with
preference for acid substrates (reviewed in Catley and Neel, 1999). This information
allowed for the discovery that PTEN actually prefers phospholipids as substrates and

8
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functions to dephosphorylate the D3 position o f PIP 2 and PIP 3 (Maehama and Dixon,
1998, Myers et al., 1998), consequently acting as a negative regulator o f PKB. In an
unstimulated cell, phosphorylated PKB levels are usually low. However, in PTENdeficient tumour cell lines and immortalized fibroblasts and tumours collected from
PTEN-deficient mice, PKB phosphorylation levels were high. In addition, P D ’kinase,
PKB and cellular growth and transformation can be further connected due to the
observation that Ras, a small GTP-binding protein that is mutated in many cancers, is
itself an activator o f P D ’kinase (Rodriguez-Viciana et al., 1994). Studies in human
tumours also revealed that PKBa is amplified in some gastric adenocarcinomas (Staal,
1987) and ovarian carcinomas (Cheng et a l, 1992). Recently a novel protein, carboxyl
terminal modulator protein (CTMP), has been identified and appears to act as a tumour
suppressor, negatively regulating PKB by inhibiting its kinase activity (Maira et al.,
2001). Furthermore, TCL-1, a proto-oncogene involved in leukemia, has also been
found to have a role in stimulating PKB activity (Pekarsky et al., 2000, Laine et al.,
2000). Therefore, it is evident that numerous PKB mutants are responsible for various
types o f cancer and that there are many important functions mediated by PKB in a P D ’K
dependent manner. Thus regulation o f PKB, such as that by ILK, has important
implications due to the involvement o f PKB in medical conditions such as diabetes and
cancer, in addition to its role in cell survival, glucose uptake, protein synthesis and the
regulation o f transcription factors and consequently, gene expression (reviewed in
Galetic et al., 1999, Andjelkovic and Hemmings, 2000).

9
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PKB Regulation and Activation
Initially, by treating cells with phosphatase inhibitors, it became apparent that PKB
activity is regulated by phosphorylation, and the kinase that was isolated from these cells
was inactivated in vitro by protein phosphatase 2A (PP2A) (Andjelkovic et al., 1996).
There is, however, a base level o f PKB phosphorylation present in unstimulated cells,
which increases upon stimulation with PDGF or pervanadate, a phosphatase inhibitor
(Andjelkovic et al., 1996, Burgering and Coffer, 1995). PDGF stimulation augments
serine phosphorylation (Burgering and Coffer, 1995) while pervanadate, a less specific
activator and insulin mimic, is a more potent PKB activator and augments
phosphorylation at both the serine and threonine residues (Andjelkovic et al., 1996).

Complete activation o f PKB requires phosphorylation at many residues. Experiments
with unstimulated human embryonic kidney (HEK) 293 cells initially mapped PKB
phosphorylation sites, which showed constitutive phosphorylation on serine-124, located
in the hinge region between the PH and catalytic domains, as well as threonine-450,
which is found in the C-terminal area (Alessi et al., 1996b). The identification o f the
threonine-308 and serine-473 sites was not recognized until cells were stimulated. Upon
stimulation with insulin or insulin growth factor-1 (IGF-1), the threonine-308/threonine309 residues, located in the activation loop o f the catalytic domain in PKB a, and the
serine-473/serine-474, found in the C-terminal domain in PKB p, were phosphorylated
(Alessi et al., 1996b). These two sites themselves were also found to be sensitive to
PI3’K inhibitors (Alessi et al., 1996b, Meier et al., 1997), such as wortmannin (Arcaro
and Wymann, 1993, Yano et al., 1993, Burgering and Coffer, 1995, Franke et al., 1995,
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Kohn et al., 1995) and LY294002 (Alessi et al., 1996). When either site was mutated to
alanine, insulin stimulation of PKB was abolished, but mutation of both sites to aspartic
acid, rendered PKB constitutively activated, and was resistant to wortmannin (Alessi et
al., 1996b). PI3’K dependent activation of PKB includes membrane localization
(Andjelkovic et al., 1997) followed by serine/threonine phosphorylation (Alessi et al.,
1996, Andejelkovic et al., 1996). While the PH domain of PKB/Akt promotes
translocation to the membrane by binding to PIP 3 (Franke et al., 1997 and Klippel et al.,
1997), phosphorylation of the serine and threonine residues is carried out by
phosphoinositide-dependent kinases (PDKs) to completely activate PKB and allow for
downstream substrate regulation (Alessi et al., 1996) (Figure 1.1).

Growth Factor
Membrane receptor
Membrane
PI3’Kinase

A

p K3,4)P2

A

PI(3,4,5)P3

PDK-1

Ser 473

Glycogen
Synthesis

Thr 30

Transcription
Cell
Survival

Protein Synthesis

Figure 1.1 . Schematic of ILK as a PDK-2 molecule in the regulation of PKB in
the PI3’K pathway. PKB is completely activated by the phosphorylation of
threonine-308 by PDK-1 in conjunction with phosphorylation of serine-473 by
PDK-2.
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PI3’K Dependent Kinase-1 (PDK-1)
The existence o f a PDK-1 molecule has been concretely identified and is responsible for
the phosphorylation of threonine-308 on PKB (reviewed by Scheid and Woodgett, 2001).
The threonine-308 site is located between the sub-domains VII and VIII o f the catalytic
domain o f PKBa, between the conserved regions, DFG-APE motifs (Hanks and Quinn,
1991). This region was identified as the activation or T-loop through the identification
of the crystal structures o f protein kinase A (PKA), cyclin-dependent kinase 2, mitogen
activated protein kinase (MAPK), and CaMK-I (Johnson et al., 1996). Isolation o f
PDK-1 by two distinct research groups demonstrated it to be the first PKB upstream
kinase by using its unique ability to phosphorylate PKB on threonine-308 in the
presence o f 3’-phosphoinositides (Alessi et al., 1997a, Stokoe et al., 1997). This kinase
was named as such because o f its phospholipid requirement for phosphorylating PKB
(Alessi et al., 1997b) and its activity is activated by the interaction o f its PH domain with
PIP 3 and PIP 2 (3,4) (Alessi et al., 1997a, Alessi et al., 1997b, Stokoe et al., 1997,
Stephens et al., 1998). PDK-1 has also been shown to regulate other second messengerregulated kinases due to their similarities to phosphorylation sites in the activation loop
of PKB. This idea was confirmed in studies that showed that PDK-1 phosphorylates a
site in the catalytic domain o f p70 S 6 K in vivo and in vitro when there was free access to
the substrate achieved by hierarchical phosphorylation C-terminal to the catalytic
domain (Pullen et al., 1998).

Two protein kinase C (PKC) isoforms have also been shown to be phosphorylated in
vitro and in vivo by PDK-1 (Le Good et al., 1998) as well as threonine 197 on PKA,
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thereby activating the catalytic subunit in vitro (Cheng et al., 1998). Interestingly,
serum-and glucocorticoid-regulated protein kinase (SGK) also appears to be another
target for PDK-1. This kinase is transcriptionally regulated and is activated by insulin,
IGF-1, peroxide and pervanadate in a PI3’K dependent manner, demonstrating
similarities to PKB (Kobayashi and Cohen, 1999, Park et al., 1999). However, for
complete activation o f PKB, phosphorylation must also occur at the serine-473 residue.
This second phosphorylation event is one o f great debate and has not yet been concretely
determined. It has been speculated that the phosphorylation o f PKB on serine-473 can
be achieved by autophosphorylation and does not require a second kinase. However, it
has been shown that phosphorylation at the serine residue can in fact be carried out by a
second, separate PDK molecule, termed PDK-2, for which ILK has been suggested.

PI3’K Dependent Kinase-2 (PDK-2)
PI3’K dependent kinase-1 (PDK-1) is responsible for the phosphorylation o f PKB at its
threonine-308 residue. However, PKB must be regulated by both PDK-1 and PDK-2
molecules, for complete activation. Integrin linked kinase (ILK) has been postulated as
a possible PDK-2 molecule responsible for the phosphorylation o f PKB on serine-473.
The serine-473 residue is homologous to the major rapamycin site o f p70 ribosomal S 6
kinase (p70 S 6 K), the threonine-389 site located C-terminal to the catalytic domain
(Pearson et al., 1995). Similar sites are also present in PKC isoforms, p90 ribosomal S 6
kinase (p90 RSK), SGK and a nuclear serine/threonine protein kinase called Ndr (Park

et al., 1999, Jensen et al., 1999, Millward et al., 1999). While there is evidence to show
that ILK can function as a PDK-2 molecule, there is still speculation o f the mechanism
o f serine-473 phosphorylation in PKB. Autophosphorylation, one mechanism proposed
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for serine-473 phosphorylation, contradicts the PDK-2 theory (Toker and Newton, 2000).
However, recent knockout studies that knock down ILK expression disprove this idea
and show that ILK is required for serine-473 phosphorylation, thus supporting the role
of ILK as a PDK-2 (Troussard et al., 2003). There are several other candidates
suggested that can directly or indirectly phosphorylate this site. A biochemical approach
where the C-terminal peptide o f PKB was used as a substrate to purify kinase activity,
identified and isolated MAPkinase-activated protein kinase 2 (MAPKAP-K2), a
component o f the stress and cytokine-activated signaling pathway (Alessi et al., 1996).
MAPKAP-K2 can phosphorylate serine-473 on PKB in vitro, but does not appear to do
the same in vivo, likely due to the fact that it is activated by cellular stresses that do not
activate PKB and inhibition of the pathway in which MAPKAP-K2 belongs does not
inhibit PKB activation in vivo (Alessi et al., 1996).

Protein kinase C-C, (PKCQ, an atypical PKC, has also been shown to have the ability to
phosphorylate a site homologous to PKB serine-473 in PKCa and PKC 8 in the Cterminal V5 domain (Ziegler et al., 1999). Phosphorylation at this site is affected by
PI3’K inhibition, which is plausible because PKC^ is also a downstream target of
PI3’kinase, and has implications in insulin signaling (Mendez et al., 1997, Standaert et
al., 1997). This may suggest a role for this kinase in the activation o f PKB. The two
kinases were linked to each other when PKC(, was illustrated as a protein that interacts
with the PH domain o f PKB (Konishi et al., 1995). Recently it was discovered that
numerous PKC inhibitors promoted PKB phosphorylation at serine-473, as well as
increasing ILK activity (Wen et al., 2003). The ability o f the PI3’K specific inhibitor

14

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

wortmannin, and PDK specific inhibitor SB 203580, to block this phosphorylation leads
to the conclusion that PKC negatively regulates PKB signaling (Wen et al., 2003).
There are still some observations that remain to be determined to fully understand the
role ofPKCC in the regulation o f PKB. However, for this thesis, the ability o f ILK to act
as PDK-2 is the most relevant.

The overall activation and regulation o f PKB has recently been reviewed and based on
current findings, the model o f PKB activation has been altered slightly (reviewed in
Scheid and Woodgett, 2003). Recent findings have determined that translocation of
PKB to the membrane by 3 ’-phosphoinositide lipids promote serine 473phosphorylation, which is necessary for subsequent PDK 1-mediated phosphorylation of
threonine-308, resulting in full PKB activation (Scheid et al., 2002). The ability o f ILK
to phosphorylate serine-473 on PKB in mammalian systems has been studied
extensively and findings will be paralleled in Drosophila studies in this thesis to further
solidify ILK as a PDK-2 molecule in the PI3’K pathway.

The Wnt/Wingless Pathway
The main effector molecule of the Wnt/Wg pathway, GSK-3/Shaggy, is also regulated
by ILK. Wingless is the Drosophila homologue to mammalian Wnt 1, and the pathway
commonly incorporates both abbreviations. Wnt proteins are recognized as a major
family o f developm entally important signaling m olecules. Wnts are a fam ily o f secreted

cysteine-rich, glycosylated protein ligands that bind membrane receptors and influence
many cellular processes including cell-cell communication, differentiation, embryonic
axis formation, migration, fate determination, development and growth in both
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vertebrates and invertebrates (Miller, 2002, Polakis 2000, Wodarz and Nusse, 1998,
Yamaguchi, 2001, Smalley and Dale, 1999). The secreted W nt proteins are
evolutionarily conserved across species (Wodarz and Nusse, 1998), as well as the genes
that are responsible for the transduction of the signals from the Wnt receptors to the
nucleus (Cadigan and Nusse, 1997, Peifer and Polakis, 2000). In Drosophila, the product
of the wingless (wg) gene is a secreted protein that is homologous to the vertebrate Wnt
proteins (Klingensmith and Nusse, 1994). The complete mechanism of the Wnt/Wg
signaling pathway has not yet been determined, but many of the components and
downstream targets are known (Figure 1.2). Generally speaking, the Wnt proteins bind to
the frizzled (fz) receptor to initiate transmission of the stimulus to the nucleus, where
genes are activated that are regulated by T-cell factor/lymphoid enhancer factor
(TCF/LEF) transcription factors (reviewed in Barker et al., 2000, Brantjes et al., 2002,
Novak and Dedhar, 1999).
Membrane

(3-catenin/arm adillo

Nucleus

Gene Transcription

Figure 1.2 - Schematic of Wnt/Wg signaling. ELK has been shown to inhibit GSK-3
and inhibit its acitivity in a PI3’k dependent manner
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The frizzled (fz)/Drosophila frizzled 2 (Dfz2) receptors are seven pass transmembrane
protein receptors with cysteine-rich extracellular domains which function as the Wnt/Wg
receptors (Bhanot et al., 1996). Activation o f the frizzled receptor in turn activates
dishevelled (Dvl/Dsh), which inactivates GSK-3/Shaggy, subsequently regulating Pcatenin/armadillo (Arm). Dishevelled is a cytoplasmic phosphoprotein with a discslarge homology region (Klingensmith et al., 1994, Theisen et al., 1994, Yanagawa et al.,
1995) that is hyperphosphorylated in response to Wnt/Wg signals (Yanagawa et al.,
1995, Willert et al., 1997). Dishevelled has a dual role in the Wnt/Wg pathway. It
serves to regulate GSK-3 levels as well as tissue polarity (reviewed in Ali et al., 2001).
GSK-3/Shaggy phosphorylation leads to P-catenin/armadillo degradation through the
ubiquitin-proteasome pathway (Aberle et al., 1997) and inhibition o f GSK-3/Shaggy
leads to higher cytoplasmic levels o f p-catenin/armadillo and nuclear translocation (Yost
et al., 1996). The discovery that P-catenin was the mammalian homologue o f armadillo
(Peifer and Wieschaus, 1990, McCrea et al., 1991) implicated it as a possible signaling
molecule, as armadillo was known to mediate the wingless pathway. An additional
protein, axin, also has a role in this pathway. Axin/D-Axin are scaffold proteins that
form a complex with GSK-3/Shaggy, p-catenin/armadillo and adenomatous polyposis
coli (APC), a tumour suprressor gene (Behrens et al., 1998). In Drosophila, D -Axin
over-expression destabilizes armadillo and it is found to be necessary for the proper
functioning o f GSK-3/Shaggy (Zeng et al., 1997) and the inhibition o f P-cateninmediated LEF-1 activation (Sakanaka et al., 1998). The mechanism by which the
activation o f Dsh inhibits GSK-3/Shaggy, thereby decreasing the phosphorylation o f pcatenin/armadillo, is still not completely understood. In Drosophila cells it has been
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shown that Shaggy is inhibited by Wg, and that over-expression o f Dfz2 and Dsh
reconstitutes Wg signaling determined by the inhibition o f Shaggy and subsequent
armadillo accumulation (Ruel et al., 1999). It was also shown that Shaggy regulation
controls armadillo levels by regulating D-Axin and armadillo phosphorylation (Ruel et
al., 1999). Integrin linked kinase has been shown to interact directly with, and
phosphorylate and inhibit GSK-3 (Delcommenne et al., 1998). However, the regulation
o f GSK-3 via ILK regulates glycogen sythesis and therefore does not act to regulate
GSK-3 within the Wnt/Wg pathway. This regulation may occur directly by or indirectly
through PKB. If independent, it may suggest two distinct pools o f GSK-3/Shaggy.

Glycogen Synthase Kinase-3 (GSK-3)
The original identification o f glycogen synthase kinase 3 (GSK-3) illustrated its ability
to phosphorylate, and consequently, inhibit glycogen synthase (Embi et al., 1980, Rylatt
et al., 1980, Woodgett and Cohen, 1984). GSK-3 is a serine/threonine kinase and
recognizes the sequence Ser/Thr-X-X-X-Ser/Thr-P where X can be any amino acid
(often proline) and the second serine (S) is prephosphorylated (Fiol et al., 1990). There
are two isoforms o f GSK-3: GSK-3a and GSK-3P (Woodgett, 1990). They differ by an
N-terminal region rich in glycine in GSK-3a, which makes GSK-3 a a larger protein with
a mass o f 51 kDa, while GSK-3 p only has a mass o f 47 kDa. These two iso forms are
structurally similar and are 98% homologous within their kinase domains (Woodgett
1990); however, they are functionally distinct. Mice lacking the GSK-3P isoform
resulted in an embryonic lethal phenotype for which the GSK-3a isoform could not
rescue indicating that the phenotype was a result o f GSK-3 p alone (Hoeflich et al., 2000).
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Studies to determine the phenotype o f mice lacking the alpha isoform have not yet been
performed.

GSK-3 is the downstream effector molecule o f the Wnt/Wg signaling pathway. Thus,
the pathway can be interchangeably termed the canonical Wnt pathway or the Wnt/|3catenin pathway (reviewed in Huelsken and Behrens, 2002, Polakis, 2000, Seidensticker
and Behrens, 2000, Sharpe et al., 2001). GSK-3 has multiple phosphorylation sites that
are required for its optimal performance. In resting unstimulated mammalian cells,
GSK-3p is phosphorylated at Y216 and is constitutively active (Hughes et al., 1993).
Therefore, it is difficult to identify the physiological significance o f this phosphorylation
event. Bacterial expression o f mammalian GSK-3 p illustrates evidence o f
autophosphorylation at this tyrosine residue, as well as at serine and threonine
phosphorylation sites, which suggest that tyrosine phosphorylation may be autocatalytic
(Wang et al., 1994). However, this was contradicted by immunoprecipitation o f GSK-3
from mammalian cells that did not show the same behaviour (Hughes et al., 1993).

GSK-3 regulation is slightly unique. In unstimulated cells, it remains active and upon
transmission o f a signal, it is phosphorylated and inactivated. GSK-3 was the first
physiological relevant substrate for PKB (Cross et al., 1995). Since then, GSK-3 itself
has been identified as an important downstream substrate in numerous signaling
pathways (reviewed in Frame and Cohen, 2001, Grimes and Jope, 2001, Woodgett,
2001). Insulin stimulation o f cells results in the inactivation o f GSK-3 in a PI3’K
dependent manner. Activation o f PKB through PI3’kinase results in phosphorylation of
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both GSK-3 iso forms: GSK-3 a is phosphorylated on serine 21 and GSK-3 P is
phosphorylated on serine 9, inhibiting GSK-3 (Cross et al., 1995). GSK-3 can also be
phosphorylated and inactivated by numerous other stimuli including growth factors that
stimulate p90RSICthrough MAP kinases, a GSK-3 inactivating kinase or MAPKAP-K1
(Brady et al., 1998, Saito et al., 1994), activators o f p70S6K such as amino acids
(Armstrong et al., 2001, Krause et al., 2002, Terruzzi et al., 2002), activators o f PKA
(Fang et al., 2000, Li et al., 2000, Tanji et al., 2002), and activators o f PKC (Ballou et al.,
2001, Fang et al., 2002). GSK-3/Shaggy is important to this work as it provides a
platform on which to further elucidate the correct role o f ILK in regulating both the
PI3’K and Wnt/Wg pathways. Continual introduction o f new molecular tools to carry
out these studies will facilitate our understanding o f cellular processes.

Microarray Technology
Studies o f several cellular processes, including signaling pathways, have been further
elucidated due to the advent o f microarray technology, which has greatly revolutionized
gene expression studies and enabled numerous advances in science. Microarrays allow
for the systematic study o f gene expression across entire genomes o f most organisms.
Prior to the invention of microarrays, Northern blot analysis or reverse transcriptionpolymerase chain reaction (RT-PCR), were employed to study the expression o f a single
gene. Microarray methodology allows for the determination o f gene expression data
about hundreds or thousands o f genes simultaneously. Microarray experiments are
carried out relatively easily considering the vastness o f their potential. Creation of the
microarray chip utilizes either oligonucleotides or amplified cDNA chosen from
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expressed sequence tag (EST) clone libraries, which is immobilized onto a glass surface
using a robotic arrayer and referred to as "probes" (Figure 1.3). It was discovered that
large scale sequencing o f cDNA would easily provide profiles o f ESTs and this concept
was implemented in EST sequencing pioneered by Venter, and later widely adopted by
others (Adams, 1993, Houlgatte, 1995, Khan et al., 1992). ESTs are short, single pass
sequences derived by sequencing the ends o f cDNA clones. They tend to be short (<
500bp) and are o f lower quality than finished genomic sequences due to their single pass
nature and provide abundant sequence information in a variety o f species including
Drosophila.
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Figure 3 - Schematic representation o f microarrav protocols resulting
in data normalization. lilieiing and cltiMering io determine up down
regulated genes
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In creating the actual microarray slide, ESTs are typically targeted to a density of
approximately 20,000 probes for an 8 cm2 slide. To determine the relative abundance o f
each o f the spotted gene sequences in two distinct samples, total RNA samples are
extracted from tissue or cells and labeled with fluorophores (Cyanine 3 and Cyanine 5)
in a reverse-transcription (RT) reaction (Shalon, 1996). These labeled cDNAs, referred
to as targets, are then mixed and hybridized onto the same chip. After hybridization the
chip is washed, and scanned to create separate images for each fluorophor and the
fluorescence intensity ratios are calculated for each element. These fluorescence
measurements are then used to determine the ratio, and thus the relative abundance, o f
each gene is represented in the two samples. Each cDNA is present in a unique spot,
therefore the relative abundance o f each transcript is not a competition factor, and both
rare and abundant transcripts can be assessed independently.

In addition to cDNA microarrays, oligonucleotide arrays are also used in microarray
studies. These arrays are similar to cDNA arrays, except that the probe spotted onto the
chip is a short synthetic oligonucleotide probe (Lockhart, 1996, Chee, 1996, Lipshutz,
1999). These oligo-arrays are processed in the same manner as cDNA microarrays,
except for the use o f less stringent washing conditions. Oligo-arrays can be more
advantageous as they eliminate the need to acquire, store, maintain and amplify
expensive EST clone sets. However, selection o f oligonucleotide probes specific to a
single gene or splice variant are a deciding factor and presents a unique challenge that
large-scale nucleotide sequence analysis and bioinformatics tools can alleviate.
Extensive bioinformatics tools are required following a microarray experiment to
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analysis the results as depicted in figure 1.3. Microarrays have provided a valuable tool
in which to study downstream effects on genes and illustrate how cells change in
response to various stimuli. In the present study, this ability o f microarrays will be
exploited to determine the effects of insulin and wortmannin on Drosophila genes.

Project Objectives

Drosophila ILK (DILK) was previously isolated by our lab and partially characterized.
The main objective o f this thesis was to further characterize Drosophila ILK.
Drosophila melanogaster Schnieder (S2) cell lines were utilized to carry out this
research. They are ideal for the study o f components o f signaling pathways as they are
relatively easily manipulated and have certain characteristics eliminating the effects o f
other pathways that may interfere with the desired results. In vivo phosphorylation
assays, in vitro kinase assays and phospho-western blot analysis were carried out to
further elucidate functions o f D-ILK. These studies will add information to growing
evidence for D-ILK as a PDK-2 molecule, responsible for the phosphorylation o f PKB
on the conserved serine residue. Microarray experiments will be employed to identify
genes that may be regulated by insulin and wortmannin, in a PI3’K dependent manner.
Further studies including RT-PCR to validate the microarray regulation o f selected
genes and to identify possible new targets that may be regulated in a PI3’K dependent
manner up or downstream o f Drosophila ILK w ill be carried out.
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CHAPTER Two
Biochemical Characterization of Drosophila Integrin Linked Kinase (ILK)

Chapter Summary
There has been extensive research on mammalian integrin linked kinase (ILK) and its
role in signaling pathways. However, the role o f Drosophila ILK still remains only
partially understood. Characterization o f this protein will aid in the understanding o f its
role in the PI3’K and Wnt/Wg pathways. In mammalian systems, ILK has been
speculated to act as a PI3’K dependent kinase-2 (PDK-2) molecule, phosphorylating
PKB on its serine-473 residue. However, this view is controversial and it is therefore
necessary to examine the role o f evolutionarily conserved ILK in other model systems.
Complete activation o f PKB occurs in conjunction with another important mediator of
the PI3’K pathway, PI3’K dependent kinase-1 (PDK-1). Integrin linked kinase has also
been shown to play a role in the Wnt/Wg pathway by phosphorylating GSK-3. The
ability o f ILK to regulate both PKB and GSK-3 provides an interesting link for crosstalk
between the two pathways. Characterization o f Drosophila ILK and determination o f
how it interacts with, and regulates downstream effector molecules, will provide
pertinent information needed for the complete understanding o f cellular signaling in
Drosophila through the PKB/ILK pathway, and illustrate its ability to act as a PDK-2
molecule.

INTRODUCTION
The PI3’K pathway is completely activated when two important regulatory molecules,
PDK-1 and PDK-2, phosphorylate threonine and serine residues on PKB respectively.
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Integrin linked kinase has been implicated as a possible PDK-2 molecule responsible for
the phosphorylation o f the serine 473 residue on PKB. Human ILK was first identified
from a yeast two-hybrid screen o f a human cDNA library, as a serine/threonine protein
kinase, which interacts with (31, 02, 03 integrins (Hannigan et al., 1996). Integrin linked
kinase is thus named due to its interactions with integrins. Integrins are heterodimeric
cell surface adhesion receptors responsible for cellular adhesion and migration through a
physical link between the extracellular matrix (ECM) and the cytoskeleton (Hynes,
1992), as well as activation o f intracellular signaling processes (Clark and Brugge, 1995,
Attwell et al., 2000). The murine form o f ILK was later identified (Li et al., 1997) and
the protein sequence was found to be 99% homologous to human ILK, thus illustrating
evolutionary conservation between species (Hannigan et al., 1996, Li et al., 1997).
Mouse and human ILK both contain 452 amino acids, resulting in a total molecular mass
o f 59 kDa. The ILK protein sequence contains three structurally distinct domains. At
the N-terminus there are four ankyrin (ANK) repeats whose structure still remains to be
determined. It has been speculated that these repeats likely contain an antiparallel 0sheet and a-helices that lie perpendicular to the 0-sheet (Sedgwick and Smerdon, 1999).
Studies have shown that these repeats can interact with a LIM domain protein, PINCH
(Tu et al., 1999) and regulate the localization o f ILK in focal adhesion plaques (Li et al.,
1999). Situated C-terminal to the ankyrin repeats is the pleckstrin homology (PH)
domain. This domain is responsible for binding to the secondary lipid products of
PI3’kinase. Lastly, the C-terminal catalytic kinase domain exhibits sequence homology
to other protein kinase domains, but lack several sequences that are observed in other
typical catalytic domains (Hannigan et al., 1996).
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The identification of ILK resulted in subsequent experiments to determine its
downstream targets. Integrin linked kinase from human embryonic kidney cells was
stimulated by fibronectin and insulin in vivo in a PI3’K dependent manner, and by 3phosphoinositides in vitro, in addition to direct phosphorylation o f PKB on serine-473
in vitro, and inhibition o f phosphorylation o f PKB on serine-473 in vivo by ILK kinase
deficient (E359K mutant) (Delcommenne et al., 1998). It was also determined that ILK
directly phosphorylates GSK-3 (Delcommenne et al., 1998). Furthermore, ILK can
down-regulate E-cadherin expression, thus promoting the nuclear translocation and
activation o f P-catenin (W u et al., 1998, Novak et al., 1998) and studies over-expressing
ILK in epithelial cells results in anchorage independent cell survival and cell cycle
progression (Radeva et al., 1997). A few years later, it was shown that over-expression
o f ILK in epithelial cells results in tumourgenesis in nude mice (Wu et al., 1998). The
anti-apoptotic role and oncogenic nature of ILK resembles that o f PKB and helps to
solidify its role as a putative serine-473 kinase. It has been shown that ILK and
PKB/Akt are constitutively activated in human prostate carcinoma cells that lack PTEN
(Persad et al., 2000). Transfection o f kinase-deficient dominant-negative ILK inhibits
serum and anchorage-independent PKB/Akt serine-473 phosphorylation therefore,
inhibiting PKB activity causing Gi cell cycle arrest and apoptosis (Persad et al., 2000).

Recently there has been growing evidence to support ILK as a PDK-2 molecule.
Initially it was reported that PDK-1 was responsible for ser-473 phosphorylation
(Balendran et al., 1999). However, this site was inducibly phosphorylated in PDK-1
knock-outs, indicating existence o f a second, PI3’K dependent ser-473 kinase (Williams
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et al., 2000). ILK has been shown to act as this serine-473 kinase, as it phosphorylates
PKB/Akt on this residue in vitro, and not on threonine-308 (Nicholson and Anderson,
2002, Delcommenne et al., 1998, Wu and Dedhar, 2001, Lynch et al., 1999, Persad et al.,
2001, Cruet-Hennequart et al., 2003). To further this notion, activation o f PKB/Akt by
both growth factor and ECM stimulation is inhibited by kinase-deficient (S343A)
dominant negative ILK (Nicholson and Anderson, 2002, Lynch et al., 1999, Persad et al.,
2001). A small-molecule ILK inhibitor was also found to inhibit serum-independent
PKB/Akt serine-473 phosphorylation (Persad et al., 2000) thus improving previous
inhibition studies with ILK that utilized P D ’kinase inhibitors, which are less specific to
ILK. To definitively illustrate ILK’s ability to act as a serine-473 kinase, ILK knockouts
were used. Small interference RNA (siRNA) and the Cre-Lox system were used to
knockout ILK in HEK-293 cells and mice respectively (Troussard et al., 2003). These
knockouts resulted in the inhibition o f PKB activity by suppressing serine-473
phosphorylation without affecting threonine-308 phosphorylation (Troussad et al., 2003).
This loss o f serine-473 was rescued by transfection o f kinase-active ILK, but not by
kinase-deficient ILK (S343A mutant), in addition to inhibiting GSK-3 phosphorylation
and decreasing the expression o f cyclin Di (Troussard et al., 2003).

The above studies collectively provide evidence that ILK does indeed exhibit the ability
to act as a PDK-2 molecule in mammalian systems. Our studies with Drosophila are
possible due to the ease o f manipulation o f this system to effectively deduce known
downstream targets o f DILK and determine the mechanism o f action. The PI3’K and
Wnt/ Wg pathways are both conserved throughout evolution and are both required in
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Drosophila. The study o f the PI3’K pathway was enhanced by the isolation and
characterization o f the Drosophila PKB/Akt mutant, Daktl, and the subsequent genetic
analysis o f Drosophila PKB/Akt (Staveley et al., 1998). It was found that D aktl
exhibited ectopic apoptosis during embryogenesis, as was indicated by induction o f
membrane blebbing, fragmentation o f DNA and membrane blebbing (Staveley et al.,
1998). Apoptosis as a result o f loss o f D aktl function was rescued by caspase
suppression in a distinct manner than with previously identified reaper/grim/hid
functions (Staveley et al., 1998), illustrating that D aktl is in fact a cell survival gene in
Drosophila, as is consistent with results from cell protection studies in mammalian
systems. This work with Drosophila PKB provides a platform for work on upstream
effector molecules, like Z)ILK, and downstream targets, to elucidate how each functions
in the pathways and regulates cellular functions. In this chapter, we show that DILK can
indeed act as a PDK-2 molecule, and phosphorylates PKB as well as Shaggy/GSK-3.

MATERIALS AND METHODS

Cell Culture and Transient Transfections
Drosophila Schneider 2 (S2) cells (ATCC) were grown in Schnieder Insect media
(Sigma) containing 10% Fetal Bovine Serum (FBS) (Gibco) and 5%
Penicillin/Streptomycin (P/S) (Gibco) and incubated at 22°C according to Ruel et al.,
1999. DILK-V5 wild-type (wt) and DILK-V5 kinase deficient (kd) (E356K mutant)
were sub-cloned into pAC5.1 A expression vector and transiently transfected into S2
cells. Thirty- six pis o f C aC f was added to 10 pg o f DNA and brought up to 300 pi
with double-distilled filtered water. This mixture was then added drop by drop, while
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vortexing, to 300 (0,1 o f 2x HBS transfection buffer (Ruel et al, 1999). After incubation
at room temperature for 45 minutes, the transfection mixture was added carefully to the
sides of plated S2 cells (3 mL per well) and incubated overnight at 22°C. The next day,
the media was changed and the cells were incubated at 22°C for another night. The cells
were induced with 60 pg/pl insulin, 0.1 mM pervanadate or 200 nM wortmannin, and
subsequently lysed in 600 pi o f gentle soft buffer (lOmM NaCl, 20mM PIPES, 0.5%
NP40, 0.05% 2-mercaptoethanol, 5mM EDTA, 100 pM, 5 pg/ml Leupeptin, 5 pg/ml
Aprotinin, 50 mM NaF, 1 mM Benzamidine).

Sequence Analysis
ClustalW was used to generate amino acid sequence alignment o f Drosophila ILK with
the known sequence o f human ILK.

Immunoprecipitation and Kinase Assays
Drosophila S2 cells were treated with the PI3’K specific inhibitor, wortmannin, at a
final concentration o f 200 nM for 10 mins prior to treatment with insulin (60 pg/pl) and
pervanadate (0.1 mM), which were added to the cells for 15 mins. Cells were then lysed
in gentle soft buffer (lOmM NaCl, 20mM PIPES, 0.5% NP40, 0.05% 2-mercaptoethanol,
5mM EDTA, 100 pM, 5 pg/ml Leupeptin, 5 pg/ml Aprotinin, 50 mM NaF, 1 mM
Benzamidine) and total protein extract was collected following centrifugation.
Endogenous DILK was immunoprecipitated from the lysate using 30 pi o f polyclonal DILK antibody in solution with 20 pi o f Protein G Sepharose beads (Amersham
Biosciences) incubated overnight, with continual shaking, in the cold room. The agarose
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beads were collected by centrifugation and washed three times with 1 mL o f gentle soft
buffer. Fractionated DILK was also collected via FPLC. Briefly, DILK-V 5 wt
transfected S2 cells were lysed in hypotonic gentle soft buffer and the protein extract
was collected and fractionated by FPLC with various column types. PKB and Shaggy
kinase assays were then performed using radio-labelled 32P Gamma ATP (Amersham
Pharmacia) as initially described by Jin et al., 2001. A master mix o f 4.75 pi o f cold
ImM ATP, 10 pi o f 5x kinase buffer (50mM MgC12, 250mM Tris-Cl pH 7.5, 5 mM
EGTA pH 7.5), 1 pi o f substrate (PKB-GST or immunoprecipitated Shaggy), and 0.5 pi
of P ATP Gamma (Amersham Pharmacia), brought up to 50 pi with double distilled
water was made. Thirty pis o f the master mix was then added to 20 pi o f DILK and
incubated at 30°C for 30 minutes. Fifty pis o f 2x SDS sample buffer was added to the
reaction and heated at 95°C for 5 minutes to denature the proteins. The samples were
electrophoresed on a 12% SDS-PAGE protein gel. The gel was then dried for 1 hour at
80°C on a gel dryer (BioRad) under vacuum and exposed overnight.

Immunoblot
Drosophila S2 cell lysate was collected for western blot analysis as described above.
Cell homogenates were electrophoresed on a 12% SDS-polyacrylamide gel and
electrophorectically transferred using a Hoefer SemiPhor semi-dry transfer unit
(Amersham Pharmacia) to PVDF membrane (Pall). After transfer, the blot was placed
in 4% Blotto for 2 hours at room temperature (4% Skim milk, 10X PBS, 25% Tween) to
block non-specific binding sites on the membrane. Following overnight incubation at
4°C with primary antibodies at a 1TOO dilution (polyclonal DILK and polyclonal Sgg)
and 1:1000 dilution (polyclonal phospho-serine 473 Akt and monoclonal V5) in 2%
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blotto (2% Skim milk, lOx PBS, 25% Tween), the membrane was then washed with 2%
Blotto 6 times for 5 minutes each time. For detection o f polyclonal DILK, PKB
phospho-serine 473, Shaggy and monoclonal V5, the membrane was incubated with
anti-rabbit or anti-mouse horseradish peroxidase secondary antibodies (Amersham
Pharmacia) and washed again with 2% blotto 6 times for 5 minutes each time.
Visualization was by chemiluminescence (Perkin Elmer) and size was determined by
comparison with high molecular weight rainbow marker (Amersham Biosciences).

In vivo Labelling
Drosophila S2 cells were grown to an approximate density o f 5x106 cells/ml and in vivo
labeling was carried out as described by Ruel et al., 1999. One mL o f master mix {1 mL
39

Schneider’s Insect media (Sigma), 0.75 pi o f P orthophosphate (Amersham Pharmacia)
per sample} was added to the cells after the removal o f the existing media and incubated
overnight at room temperature in phosphate free media. The next day, insulin (60 pg/pl)
was added to the cells and incubated for 15 minutes. The media was aspirated off and
the cells were centrifuged for 10 minutes at 15000g at room temperature before the
addition o f 600 pi o f gentle soft buffer. The supernatant was collected and DILK was
immunoprecipitated overnight using 30 pi o f DILK antibody/sample. The protein was
electrophoresed on a 12% SDS-PAGE gel and visualized by autoradiography.

PKB-GST Fusion Protein and Purification
PKB-GST was purified as outlined in the Promega GST Fusion Protein protocol. PKB
was previously sub-cloned into the pGEX 4T-1 vector (Amersham Pharmacia) and
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subsequently transformed into E. coli BL-21 cells and grown in 100 mL YT broth
(0.01% tryptone, 0.005% yeast, 0.005% NaCl) overnight. The next day the samples
were diluted to 1 L with fresh YT broth and grown at 37°C (shaker) until they reached
an OD o f 0.5. Four millilitres o f Isopropyl-beta-D-thiogalactopyranoside (IPTG)
(Invitrogen) (final concentration 0.1 M) was added to the broth mixture. Induction was
performed at 37°C in covered flasks for 0 hrs (no IPTG) and 4 hrs. The cells were
centrifuged immediately at 10 OOOg for 10 minutes at room temperature. The pellet was
dissolved in 10 mL o f lOx PBST (phosphate buffered saline/tween). Sonication was
performed in the Sonic Dismembrator 60 (Fisher Scientific) 3 times for 15 seconds at
level 3. Samples were then centrifuged at 15 OOOg for 20 minutes and the supernatant
was collected. Five hundred pis o f slurry {250 pi o f glutathione beads immobilized on
cross-linked 4% beaded agarose (Sigma)} was added to the supernatant and nutated
overnight at 4°C. The samples were then centrifuged at lOOOg for 30 seconds to pellet
the glutathione beads. The supernatant was removed and the beads were washed with 10
mL o f lx PBST plus inhibitors (15mM NaCl, 16mM Na2H P 0 4, 4mM NaH2P 0 4, 0.1%
Triton xlOO, 50mM NaF) and incubated with gentle shaking for 10 minutes, repeated
three times. The remaining supernatant was removed and 10 mL elution buffer (20mM
reduced glutathione, lOOmM Tris pH 8.0, 150mM NaCl, 0.1% Triton xlOO pH 7.0) was
added to the samples, and nutated for 4 hours at 4°C. The sample was then centrifuged
at lOOOg for 1 minute to pellet the beads. The supernatant containing the protein was
collected and dialyzed. Dialysis tubing (Sigma) was saturated in 1 L o f dialysis buffer
(25 mM Tris pH 7.4, 1 mM EDTA, 0.2 mM EGTA,1 mM DTT, 50% glycerol) before
the sample was added. The protein was added to the tubing, and it was clamped and
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incubated on a stirrer overnight at 4°C. The dialysis buffer was changed the next
morning and incubated for 3 hours. The protein was collected and lx the volume of
glycerol was added before storage at -20°C.

Image Quantification
Images were quantified by Adobe Photoshop and represented as the difference in mean
intensities.

RESULTS

Drosophila ILK Shows High Sequence Homology to Human ILK
Integrin linked kinase (ILK) has been shown to be highly conserved throughout
evolution. The sequence o f DILK encodes a conceptual reading frame that translates to
a protein o f 448 amino acids (Figure 2.1). Alignment o f human and Drosophila ILK
showed a high degree o f homology (Figure 2.1). Human ILK and Drosophila ILK share
59% similarity at the amino acid level (GenBank accession numbers AAH01554 and
AAF28365 respectively). The DILK sequence also encodes N-terminal ankyrin repeats,
a central PH domain and a C-terminal kinase catalytic domain, as is found in human ILK.
Drosophila ILK contains 4 ankyrin repeats, and all 4 ankyrin domains generally exhibit
the conserved consensus sequence, with only 10 amino acid differences across all 4
repeats. The PH domain o f Drosophila ILK is also conserved, exhibiting only 3 amino
acid differences within the conserved residues important for binding o f the
phosphatidylinositol lipid products. The DILK kinase catalytic domain is structurally
similar to that o f human ILK and contains the important conserved glutamic acid (E) at
position 356 (359 in hILK) which when mutated, renders the kinase inactive.
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Figure 2.1. Amino acid sequence alignment o f ILK homologues. The deduced amino
acid sequence o f Drosophila ILK (GenBank accession number AAF28365) was
compared to human ILK sequence (GenBank accession number AAH01554). Identities
are shown as asterisks, while dashes represent gaps introduced to maximize sequence
alignment. The ankyrin, PH and kinase catalytic domains are conserved between the
species. The four ankyrin repeats (consensus sequence -G-TPLH-AA—GH—V —LL-GA—N) are in bold and stretch from residues 34-130. The PH domain (consensus
sequence GWLXK— GXXXK
WKXRW) is italicized and stretches from residues
179-211. Amino acids underlined within the PH domain indicate residues important for
the binding of phosphatidylinositol lipid products. The kinase domain (bolded) begins at
residue 186 and extends to the end o f the protein. The A indicates the position in the
kinase domain that when converted from E to K renders the kinase inactive. The 2
protein sequences are 59% similar and the amino acid differences are shown in red.
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* * * *

*
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In vivo Phosphorylation of DILK
In order to analyze the effects o f insulin on the phosphorylation o f DILK, we performed
in vivo labelling using S2 cells. Radiolabelled 32P orthophosphate was added to
Drosophila S2 cells and after overnight incubation and insulin treatment, the lysate was
collected. DILK was immunoprecipitated, using polyclonal DILK antibody and its
phosphorylation in vivo was detected by autoradiography (Figure 2.2). In untreated cells,
the phosphorylation o f DILK was 4.3 times greater than the control. The control did not
contain immunoprecipitated DILK and therefore the slight expression o f DILK can be
attributed to endogenous activity. After treatment with insulin, DILK phosphorylation
was 16.3 times greater than the control and 3.8 times greater than the non-insulin treated
cells.

PI3’K Dependent Phosphorylation of PKB by DILK in vitro
To correlate the insulin induced phosphorylation o f DILK with its ability to
phosphorylate downstream targets in vitro, we performed an in vitro kinase assay. PKBGST, isolated and purified from BL-21 cells, was used as a substrate for
immunoprecipitated DILK from Drosophila S2 cells. The in vitro kinase assay used
radiolabelled 32P and was incubated for 30 minutes at 30°C to illustrate the ability of
Drosophila ILK to phosphorylate substrate PKB-GST (Figure 2.3). Insulin, a PI3’K
activator, phosphorylation o f PKB-GST was 17 times greater than the control.
Pervanadate, a phosphatase inhibitor and a less potent stimulant o f DILK activity,
phosphorylation o f PKB-GST was 1.5 times less than that exhibited by insulin. The
phosphorylation o f PKB-GST was inhibited by wortmannin, a PI3’K specific inhibitor,
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Figure 2.2. In vivo phosphorylation o f endogenous DILK. In vivo labelling with 32P
orthophosphate was performed in Drosophila S2 cells, followed by treatment with
insulin for 15 mins, and subsequent lysis in gentle soft buffer. DILK was
immunoprecipitated with DILK polyclonal antibody. The control (lane 1) did not
contain immunoprecipitated DILK. Immunoprecipitated DILK (lane 2) was untreated
and lane 3 was treated with insulin. A Western blot using the DILK antibody illustrated
the presence o f endogenous ILK.
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Figure 2.3. PI3’K dependent phosphorylation o f PKB by DILK in vitro. Drosophila S2
cells were treated with insulin, pervanadate and wortmannin and DILK was isolated with
a polyclonal DILK antibody. The control lane shows the untreated sample (lane 1).
Insulin alone was added to the cells for 15 minutes (lane 2), pervanadate for 15 minutes
(lane 3) and wortmannin for 15 minutes (lane 4). In lanes 5 and 6 wortmannin was
added to the cells 10 minutes prior to treatment with insulin and pervanadate, which was
then incubated for 15 minutes. A PKB kinase assay was then performed using radio
labelled 32P. A western blot using anti-D-ILK antibody illustrated the relatively equal
levels o f endogenous D-ILK.
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resulting in 100 times less PKB phosphorylation than pervandate. W hen administered
prior to treatment with either insulin or pervanadate, its inhibitory affects were
essentially irreversible. Wortmannin plus insulin showed 1.1 times greater
phosphorylation o f PKB than wortmannin alone, and wortmannin plus pervanadate
showed 1.6 times less phosphorylation o f PKB than wortmannin plus insulin. The
control blot shows that DILK was present in relatively equal amounts in each treatment
group.

Drosophila ILK Phosphorylates PKB at serine 505 in vivo in a PI3’K Dependent
Manner
In mammalian systems, it has been shown that ILK phosphorylates PKB at serine-473.
However, no study has shown the in vivo phosphorylation o f this residue by DILK. To
determine this, Drosophila S2 cells were transiently transfected with DILK-V5 wt or
DILK-V5 kd (E356K mutant) and treatment with insulin (60 pg/pl), pervanadate (0.1
mM) and wortmannin (200 nM). A PKB phospho-serine 473 western blot determined
phosphorylation at this residue (Figure 2.4). Insulin increased the phosphorylation of
PKB/Akt at serine-505 (homologue to mammalian serine-473) in vivo (Figure 2.4a).
Cells transfected with DILK-V5 wt in the presence o f insulin showed 2.3 times the
phosphorylation at PKB serine-505, as compared to the non-transfected cells in the
presence o f insulin and 2.3 times the phosphorylation o f unstimulated transfected cells.
Kinase deficient DILK stimulated with insulin demonstrated 1.3 times less
phosphorylation than DILK-V5 wt insulin treated cells. Similarly, cells treated with
pervanadate, a phosphatase inhibitor, showed 1.9 times more phosphorylation o f serine505 in DILK-V5 wt transfected cells than in DILK kinase deficient transfected cells
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Figure 2.4. a) Insulin increases the phosphorylation o f PKB/Akt at serine-505 in vivo.
Drosophila S2 cells were transiently transfected with D-ILK-V5 wt or D-ILK-V5 kd
(E356K mutant) in the absence or presence o f insulin (60 pg/pl), a P B ’-K activator, for
15 mins. Total protein extract was collected 48 h after treatment and subjected to
phospho-westem blot analysis using anti-pS473-Akt antibody. The blot was reprobed
with anti-V5 antibody to illustrate transfection efficiency, b) Pervanadate increases the
phosphorylation o f PKB/Akt in Drosophila S2 cells in vivo. Drosophila S2 cells were
transiently transfected with V5-tagged D-ILK wild-type (wt) or D-ILK kd (E356K
mutant). The transfected cells were treated with 0.1 mM pervanadate (a phosphatase
inhibitor) for 15 mins. Cells were lysed in gentle soft buffer and total protein was
extracted and subjected to phospho-westem blot analysis using anti-pS473-Akt antibody.
Transfection efficiency was estimated by reprobing the blot with anti-V5 antibody, c)
PI3’-K inhibitor wortmannin blocks the phosphorylation o f PKB/Akt in Drosophila S2
Cells in vivo. Drosophila S2 cells were transiently transfected with D-ILK-V5 wt in the
absence or presence o f pervanadate (0.1 mM), a phosphatase inhibitor, or wortmannin
(200 nM), a PI3-K inhibitor, or a combination o f both. Total protein was extracted after
48 h and subjected to phospho-westem blot analysis. Reprobing o f the blot with anti-V5
antibody illustrated the transfection efficiency.
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(Figure 2.4b). Wortmannin, a PI3’K specific inhibitor, negated PKB serine-505
phosphorylation when applied alone, and cells treated with wortmannin prior to
treatment with pervanadate exhibited 1.6 times less phosphorylation at this residue
(Figure 2.4c). Phosphorylation in the presence o f pervandate was 2.0 times greater than
DILK-V5 wt transfected cells not treated with pervanadate. The transfection levels of
DILK-V5 are illustrated as a control in each experiment and shows relatively equal
expression across the samples.

Phosphorylation of Shaggy by DILK in vitro
ILK also functions to regulate GSK-3 in mammalian systems. However, the ability of
Drosophila ILK to phosphorylate Shaggy (homologue to mammalian GSK-3) has yet to
be determined in vitro. Therefore, we looked at the ability o f DILK to phosphorylate
Shaggy in vitro using fast performance liquid chromatography (FPLC) fractionated
DILK samples for the in vitro kinase assay (Figure 5). Radiolabelled

P Gamma ATP

was added to purified DILK and Shaggy immunoprecipitated from Drosophila S2 cells
and incubated for 30 minutes at 30°C. FPLC fractions previously collected show the
highest amounts o f DILK in fractions 6 and 9, with decreasing amounts in fractions 7,
10, 8, and 5. However, the highest levels o f Shaggy phosphorylation were observed in
lanes 7 through 9, with bands shifted upwards on the gel correlating to phosphorylation.
A Shaggy immunoblot illustrates the presence o f consistent amounts o f Shaggy for each
sample.
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Figure 2.5. Phosphorylation o f Shaggy by DILK in vitro. Endogenous Shaggy was
immunoprecipitated from Drosophila S2 cells with a polyclonal Sgg antibody. Equal
volumes o f FPLC fractionated DILK samples (fractionated from cell lysate collected
from Drosophila S2 cells transfected with DILK-V5 wt) were added to radiolabelled 32P
ATP to observe their ability to phosphorylate Shaggy in vitro as determined by an in
vitro kinase assay. FPLC fractions contain varying amounts o f DILK. Western blots
with Sgg polyclonal and V5 monoclonal antibodies illustrate the relatively equal
amounts o f Shaggy and the amounts o f DILK that were present in each sample.
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DISCUSSION
Signaling through the PI3’K pathway is responsible for many cellular events such as cell
survival and apoptosis. Misregulation o f these events at certain stages leads to
tumourgenesis. Regulation o f these processes is carried out by the major effector
molecule o f the pathway, PKB (reviewed Scheid and Woodgett, 2001; Scheid and
Woodgett, 2003). Integrin linked kinase is an upstream regulator o f PKB and its role in
the regulation o f numerous cellular pathways has been studied extensively in
mammalian systems, and ILK itself has been characterized in many respects
(Delcommenne et al., 1998, Troussard et al., 2003). However, Drosophila ILK
characterization is substantially less complete, as is the determination o f its functions in
signaling pathways. Various signaling pathways collaborate to regulate cellular
proliferation and growth, and the importance o f ILK in each pathway separately, in
addition to its ability to regulate crosstalk between pathways, is o f extreme importance.
Sequence alignment o f DILK with human ILK showed 59% similarity at the protein
level, and conservation o f three conserved domains, the ankyrin, PH and kinase catalytic
domains. Drosophila ILK contains 4 ankyrin repeats, as was also found in human ILK,
and the four ankyrin repeats are conserved with only 10 amino acids differing from the
consensus sequence. In general, the PH domain lacks primary sequence similarity
between species and as a result, its structural homology cannot be assured, but
similarities in structure lean toward a common function (reviewed in Rebecchi and
Scarlata, 1998). The PH domain is conserved in Drosophila ILK with differences in
only 3 residues required for binding to phosphatidylinositol lipid products. The DILK
kinase domain exhibits similarity to the human ILK kinase domain with conservation at
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amino acid residue 356 (homologue to mammalian 359), which when mutated, renders
the kinase domain o f ILK inactive, which is necessary for dominant negative studies. It
is important to note that there is still speculation as to whether or not ILK exists as a
kinase, as its catalytic domain differs from that o f other typical kinase domains.
However, mammalian ILK has been shown to behave as a bona fid e serine-threonine
kinase, able to phosphorylate other substrates besides PKB/Akt, such as myosin light
chain, myosin phosphatase target subunit, and myosin phosphatase inhibitors, PHI-1 and
CPI-17 (Deng et al., 2001, Deng et al., 2002, Muranyi et al., 2002). In addition, the
recent identification o f a lipid-raft associated PKB serine 473 kinase, separate from
PDK-1, PKB or ILK, antagonizes the PDK-2 theory, although its identity is still
unknown (Hill et al., 2002).

Drosophila ILK is implicated as a PDK-2 in this study. Drosophila ILK is shown to be
an effector molecule o f the PI3 ’K pathway, regulated in a PI3 ’K dependent manner. In
vivo labeling o f DILK illustrates its ability to be regulated in a PI3’K dependent manner,
as it is activated in response to insulin. The solidification o f DILK regulation by the
PI3’K pathway is important for the validity o f other results, as it cannot phosphorylate
effector molecules, such as PKB, if it is not part o f the PI3’K pathway. DILK functions
in the PI3’K pathway to phosphorylate PKB substrate in vitro as well as in vivo. The
PKB in vitro kinase assay shows that DILK can phosphorylate PKB, and that the
phosphorylation is regulated in a PI3’K dependent manner. Insulin, a PI3’K stimulant,
greatly increases PKB phosphorylation, consistent with mammalian studies
(Delcommenne et al., 1998), whereas wortmannin, a PI3’K inhibitor, essentially negated
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it. Studies in mammalian systems have shown that ILK can act as a PDK-2, responsible
for the phosphorylation o f PKB at serine 473, resulting in complete activation o f PKB in
conjunction with phosphorylation o f threonine 308 by PDK-1 (Nicholson, and Anderson,
2002, Delcommenne et al., 1998, Wu and Dedhar, 2001, Lynch et al., 1999, Persad et al.,
2001, Cruet-Hennequart et al., 2003). PDK-1 was initially proposed to also be
responsible for stimulating the phosphorylation at the serine-473 residue (Balendran et
al., 1999). This site was later found to be inducibly phosphorylated in PDK-1 knock-out
cells, indicating the existence o f a separate, distinct serine-473 kinase (Williams et al.,
2000). Our data support the mammalian results. We show that DILK is able to
phosphorylate PKB on serine-505, the Drosophila homologue o f serine-473, in vivo,
thereby confirming its role as a PDK-2 molecule. Interestingly, it has been reported that
the PI3’K pathway and PKB/Akt activation may not be affected in Caenorhabditis
elegans ILK mutants {pat-4 (C.elegans homolog ILK) null mutant} and Drosophila ILK
mutants (point mutation at W

911

which introduces a stop codon and truncates the protein,

and site-directed mutations; K219M, P358S and E359K) (Zervas et al., 2001,
MacKinnon et al., 2002).

In addition to its role in the PI3’K pathway, ILK also regulates effector molecules in the
Wnt/Wg. We demonstrate that DILK is able to phosphorylate Shaggy, the homologue to
mammalian GSK-3, in vitro using FPLC fractionated DILK, which coincides with
findings in mammalian systems (Delcommenne et al., 1998). FPLC fractionation of
DILK resulted in fractions that contained varying amounts o f DILK. Interestingly,
fractions containing the most DILK did not directly parallel the highest levels o f Shaggy
phosphorylation. This may be due to a dose dependent response with lesser amounts of
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DILK required for optimal phosphorylation, as higher amounts (i.e. saturation) o f DILK
may hinder phosphorylation due to masked binding sites or altered conformations.
Alternatively, in vivo there are other proteins that bind to DILK, and interfere with its
ability to phosphorylate Shaggy/GSK-3. These proteins, if bound, may not have the
same effect on PKB and can explain the results obtained with GSK-3/Shaggy. However,
the upshift in bands illustrates that Shaggy phosphorylation did occur, predominantly in
lanes seven through nine. Unpublished work from our lab offers more evidence of
DILK’s role in the regulation o f Shaggy, as well as the role o f Dishevelled in regulating
the Wnt/Wg pathway. Continued research will solidify the role o f DILK in the
regulation o f Shaggy and other effector molecules o f the Wnt/Wg pathway. Speculation
as to the existence o f two distinct pools o f mammalian GSK-3 creates the possibility of
more complex regulation. GSK-3/Shaggy may exist as a molecule that is regulated by
insulin through the PI3’K pathway to regulate glycogen synthase levels. However, a
separate pool may exist that is regulated by the Wnt/Wg pathway thereby, regulating pcatenin levels. The ability o f ILK to act as PDK-2, and regulate both pools is possible.
Further work will decipher the actual components and design o f the Wnt/Wg, as well as
the PI3’K pathway, and the complete understanding o f ILK as a PDK-2 molecule be
achieved.
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CHAPTER THREE
Identification of Candidate Drosophila Genes Regulated by Insulin and
Wortmannin Using Microarray Technology

Chapter Summary
Insulin is a known stimulant o f the PI3’K pathway, increasing the activity o f both ILK
and PKB and this action is negated by wortmannin, a PI3’K specific inhibitor. The
effects o f both insulin and wortmannin have been studied extensively at the protein level.
However, their ability to regulate genes at a transcriptional level has not been well
documented. Microarrays determine the regulation o f a vast number o f genes
simultaneously at the transcriptional level, allowing for the collection o f data and
information that was otherwise unattainable using traditional approaches. In our current
study, insulin and wortmannin, were shown to regulate a number o f genes in Drosophila
S2 cells. Genes showing significant changes were then extracted from the resultant gene
list. Two genes, Dream, and Tau, were selected. Dream was shown to be up-regulated
by insulin and Tau was shown to be down-regulated by insulin, but up-regulated by
wortmannin. Dream has been further analyzed by reverse transcription-polymerase
chain reaction (RT-PCR) to confirm the microarray results.

INTRODUCTION
Microarrays have greatly enhanced gene expression studies as a tool capable of
determining the transcriptional status o f thousands o f genes simultaneously, as well as
exploitation in other disciplines (reviewed in Ali and Crawford, 2002). DNA
microarrays are important in many areas o f research, including the identification o f

51

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

new genes (Petkov et al., 2004), and the establishment o f downstream targets o f
characterized loci (Wells et al., 2003), as well as providing an excellent avenue to study
gene regulation in both normal and diseased tissue (Alon et al., 1999, Kao et al, 2003,
Schena et al., 1995). In addition, gene arrays can be employed to identify target genes
that are up or down-regulated in response to stimuli. Insulin and wortmannin are
external stimuli that regulate the PI3’K pathway antagonistically. At the protein level,
insulin acts to increase the phosphorylation o f numerous substrates, while wortmannin
inhibits this event (Delcommenne et al., 1998, Persad et al., 2001). However, their
internal downstream affects on gene expression has progressed slowly due to the
limitations incurred by traditional approaches such as Northern blot analysis and reverse
transcriptional polymerase chain reaction (RT-PCR). Microarrays are much more
efficient, accurate and sensitive than either one o f these single gene analysis methods.
The difficulty of microarrays lies within the analysis o f the vast amounts o f data that is
generated. Plodding through the data to extract relevant biological information is aided
by numerous software programs that serve to normalize, filter and cluster important
information (reviewed in Stevens and Ali, 2004 submitted). This chapter will illustrate
the use o f microarrays to determine genes that are regulated by insulin or wortmannin
treatments in Drosophila S2 cells to further our understanding o f these two important
stimuli. These results will enable us to draw conclusions about the regulation of
numerous genes at the transcriptional level, thereby adding another dimension of
understanding to what is already known about genes based on experiments at the protein
level.
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MATERIALS AND METHODS
Cell Culture
Drosophila Schneider 2 (S2) cells (ATCC) were grown in Schneider insect media
(Sigma) containing 10% Fetal Bovine Serum (FBS) (Gibco) and 5%
Penicillin/Streptomycin (P/S) (Gibco) and incubated at 22°C. Cells were split at a
density o f 5 x 106 cells/ml and 3 ml were plated into 6 well plates for subsequent
treatments.

Trizol Total RNA Isolation
Drosophila S2 cells were grown to an approximate density o f 5 x 106 cells and treated
with insulin (60 pg/pl) and wortmannin (200 nM) for 15 minutes. Control (no
treatment), insulin and wortmannin treated cells were centrifuged at 700 rpms in a Jouan
Br4i S40 centrifuge forlO mins at 4°C. The supernatant was removed and 1 mL of
Trizol (Invitrogen) was added, pipetted up and down to lyse the cells, and incubated at
room temperature for 5 mins to completely dissociate nucleoprotein complexes. Two
hundred pis o f chloroform per 1 mL o f Trizol was added to each sample and shaken
vigourously for approximately 15 seconds and incubated at room temperature for 2-3
mins. The samples were then spun at 12000g for 20 mins at 4°C. The top layer o f the
three resultant layers contained the total RNA and was removed and placed into a new
eppendorf tube. Five hundred pis o f ice cold isopropanol per 1 mL o f Trizol was added
to precipitate the RNA. After gentle shaking to allow the isopropanol to distribute
through the sample, the sample was incubated for 15 mins at room temperature, then
centrifuged at 12000g for 10 mins at 4°C. The supernatant was removed and the RNA
pellet was washed twice with 1 mL o f 70% ethanol spinning it at 7500g for 5 minutes at
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4°C after each wash. The RNA pellet was then dried at room temperature for
approximately 15 minutes and then dissolved in 50 pi o f DEPC treated water and
incubated for 10 minutes at 55-60°C. Five microlitres o f extracted total RNA was
electrophoresed on a 1% agarose gel and an optical density (OD) reading at 260 nm was
carried out to determine concentration.

Direct Labeling of Total RNA from Drosophila S2 Cells for Microarray Analysis
Drosophila 12K EST microarrays were obtained from the Canadian Drosophila
Microarray Center. Approximately 60pg o f total RNA isolated by the Trizol isolation
method was used per sample. First strand cDNA synthesis, hybridization, and washing
were carried out as outlined in the direct labeling protocol from the Canadian
Drosophila Microarray Center ('http://www.flvarravs.com/download file/1. Sixty pg of
total RNA from control, insulin, and wortmannin treated cells were reversed transcribed
to synthesize first strand cDNA using Superscript™ Reverse Transcriptase (Invitrogen
Life Technologies). Cyanine 3-dCTP and Cyanine5-dCTP fluors (Perkin Elmer) were
incorporated into the cDNA and reciprocal labeling was performed to eliminate any bias
in dye incorporation. After target precipitation, it was hybridized to the microarray chip.
Ninety microlitres o f hybridization solution containing DIG Easy Hyb solution (Roche),
yeast tRNA (Sigma), and calf thymus DNA (Sigma), was pipetted onto the chip and
covered by a coverslip to ensure no air bubbles. Following hybridization at 37°C for 1218 hours, the chip was washed with varying stringencies (room temperature IX SSC to
remove the coverslip, 50°C IX SSC plus 0.1% SDS 3 times for 15 minutes each time at
50°C, room temperature IX SSC for 30 seconds, and then room temperature 0.1X SSC
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for a few seconds), dried (5 mintues) and scanned using a Scanarray 4000 XL laser
scanner and Scanarray Express™ software.

RT-PCR
RT-PCR was performed to further validate the microarray results. Five micrograms o f
total RNA from Drosophila cells was used for first strand cDNA synthesis in the
presence o f RNasin (Promega) and Superscript™ Reverse Transcriptase (Invitrogen
Life Technologies) as outlined in the enzyme manufacturer’s protocol (Invitrogen Life
Technologies). Ten percent o f the first-strand reaction was used for PCR reactions.
Primers were designed to specifically amplify genes o f interest (Dream) and the control
gene (DILK). Polymerase chain reaction (PCR) conditions were determined empirically
to find the linear range of amplification for Dream and reactions were conducted using
Taq polymerase in 200 mM Tris-HCL (pH 8.4), 500 mM KC1, 1 mM MgCl2, 1 pi o f 10
mM dNTPs, and 0.1 pi o f 10 pM for the DREAM specific primers (5’GAGCGGTTCGATAACAAGAAC-3 ’ and 5 ’-TGGAATTTGGCGGTCTTTGGATTG3’) and 1pi o f 10 pM for the control DILK primers
(5 ’GGA ATT CAT GG AGG AC AT ATTCC ACT GGT GCCGC— 3 ’ and
5’TCACTCGAGGCGGCGCATCTTCTCCAGAATGGGAAC— 3’). Dream
amplifications were preceded by a 5 minute denaturation step at 95 °C, then immediately
cycled 35 times at 95°C for 45 seconds, 57°C for 45 seconds, and 72°C for 1 minute.
The amplification o f DILK was preceded by a 5 minute denaturation step at 95 °C, then
immediately cycled 27 times at 92°C for 1 minute, 55°C for 1 minute and 72°C for 2
minutes. One tenth o f each reaction was electrophoresed on a 1% agarose gel and
visualized under UV light.
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Data Analysis
Acquired scanned images were quantified with Quantarray™ software and
GeneTraffic™ software (Iobion Informatics) was used to analyze the data. Initially,
spots o f low intensity and high variability were filtered out using several parameters as
outlined in Table 1.
Flag Parameters
y

LEX.E to background intensity ratio less than '*

^

LEX.R to background intensity ratio less than

1

LEX.E intensity less than I

times average background

^

LEX.R intensity less than J

times average background

^

LEX.E intensity less than I 50

^

LEX.R intensity less than

Background Subtraction
p-

Subtract local background values from spot intensities______________________

Table 3.1: Parameters used for the initial filtering o f low intensity spots. LEX.E
represents the insulin or wortmannin treated spot intensities. LEX.R represents the
control spot intensities.
Normalization was completed by LOWESS (Locally Weighted Scatter Plot Smoother)
sub-grid method. The intensity values for each spot in a sub grid (repeated for every
sub-grid on a chip) were normalized with respect to the data distribution in the
immediate neighbourhood o f a spot’s intensity. Therefore, normalization o f dim spots is
not influenced by the absolute values, or by the distribution pattern, o f any bright spots
found on the chip (GeneTraffic™ User Manual, Iobion Informatics). Screened data was
organized into gene tables which were then further filtered by comparing spot intensity
ratios between the experimental and control chips (Table 2). These resultant filtered
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genes were hierarchically clustered to determine "distances" between the data elements
as a means to determine similarity, the inverse o f distance. Agglomerative methods
which start with each item in its own cluster, and then successively combine the two
closest clusters until all items are grouped together were used to cluster the data.
Gene Table Filters
i

|
j

*

Remove genes with percentage o f values present lower than 100
Rem ove genes w ithout at least 1 observation(s) with absolute values o f log: ratio
greater than 1

Table 3.2: Parameters used for filtering o f genes that showed no significant change in
expression between control and treated cells across the various concentrations tested.
From the clustered data, genes o f relevance were identified by setting the value o f the
log2 ratio to be at least >1 and <-1 thus consequently exhibiting at least a 2 fold change
in expression (up or down-regulation respectively). Genes categorized with this fold
change had 3 o f 4 or 4 o f 4 possible spots “lit” (i.e. each gene has been spotted twice on
one chip, and these two spots on a separate chip were also reciprocally hybridized for
each treatment, for a total o f 4 spots per gene).

RESULTS
Microarray Analysis: Image Acquisition and Quantification
Microarray chips were scanned with ScanArray Express™ and qualitative images were
produced. A representative image o f insulin treated Drosophila S2 cells, displaying one
sub-grid o f the microarray chip, is shown in figure 3.1. These images represent
qualitative results that provide a visual indication o f changes in gene expression as a
result o f the treatments. Images were scanned initially at a resolution o f 50 microns to
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Figure 3.1. Representative qualitative images scanned at 5 microns using ScanArray
Express™ are comprised o f one sub-grid from reciprocally labeled insulin treated
Drosophila S2 cells. Composite images are comprised o f the independent Cyanine 3
and Cyanine 5 images. Increase in gene expression as a result o f treatment with insulin
as compared to the control is represented by red spots, decrease in gene expression as a
result o f insulin as compared to the control is represented as green spots and no change
in gene expression is represented by yellow spots.
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provide a visual template o f the chip allowing for selection o f a smaller area composed
of only the spot grid, which was then scanned at a resolution o f 5 microns producing a
more accurate picture. Red spots indicate up-regulation o f gene expression in response
to the insulin treatment. Green spots indicate down-regulation o f gene expression
compared to the control, and yellow spots represent equal gene expression between the
control and insulin treated cells. In the reciprocally labeled chips (image not shown) red
spots indicate down-regulation o f gene expression in response to the insulin treatment
and green spots indicate up-regulation. Similar images were created upon scanning the
wortmannin treated microarray chips (images not shown). The existence o f numerous
red and green spots in the scanned images illustrated the up or down-regulation o f a vast
number o f genes by the two treatments.

Hierarchical Clustering: Flagging, Filtering, Normalization and Data Reduction
Insulin and wortmannin treatments were tested to detect any corresponding changes in
gene expression. W ith the inclusion o f reciprocal hybridization, a total o f four 12K
Drosophila chips were used for a total o f approximately 96000 initial data points that
could potentially exhibit detectable changes induced by insulin or wortmannin. Initial
filtering and normalization based on the parameters shown in Table 3.1 drastically
reduced the number o f data points and further selection o f these filtered genes based on
the filtering parameters in Table 3.2 reduced the number even more to a manageable
1151 data points. These 1151 data points were then hierarchically clustered (Figure 3.2)
and genes that were up or down-regulated by insulin or wortmannin or both were
identified as having at least a two fold change in gene expression. A schematic diagram
illustrates the necessary steps required to reduce the initial data points to a manageable
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Figure 3.2. Data reduction by hierarchical clustering o f microarray data for insulin and
wortmannin treatments. From the resultant gene list, two genes, Dream and Tau, were
selected. Dream is shown in the first section o f clustered data with the lane enlarged to
show up-regulation by insulin. Tau is shown in the second section o f clustered data with
the lane enlarged to show down-regulation by insulin and up-regulation by wortmannin.
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Dream

Tau

number o f regulated genes (Figure 3.3). Hierarchical clustering (2 fold change in gene
expression and 3 or 4 spots “lit”) resulted in 30 genes that were up-regulated by insulin
and 41 genes that were down-regulated by insulin, in addition to 70 genes that were upregulated by wortmannin and 62 genes that were down-regulated by wortmannin (Figure
3.3). From this list, two genes o f interest, Dream and Tau, were initially selected from
the clustered data due to relevance to the present study (GenBank accession numbers
AA438962 and B I173687 respectively). Dream was shown to be up-regulated by
insulin (1.05) and Tau was found to be up-regulated by wortmannin (1.07) and downregulated by insulin (-1.94). RT-PCR was performed on Dream to validate the
microarray results.

RT-PCR Verification of the Up-Regulation of Dream by Insulin
Verification o f the up-regulation o f Dream by insulin, as was determined by the
microarray experiment, was carried out using RT-PCR (Figure 3.4). RNA samples were
reversed transcribed to cDNA and then amplified by specific primers to Dream. Dream
was detected at a base level in untreated cells and this level was increased by treatment
with insulin. A control containing no DNA showed no detectable band. Drosophila
ILK was used as a loading and reaction control. It was amplified in relatively equal
amounts in both the control and insulin treated cells.
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Figure 3.3. Schematic representation o f data analysis resulting in the determination of
genes that exhibited at least a 2 fold change in expression pattern. The necessary steps
for the acquisition o f results from the microarray experiments using 12K Drosophila
microarray chips include initial filtering and normalization, gene table filtering and
hierarchical clustering. The genes obtained following the ‘secondary’ filtering were all
clustered together resulting in gene lists for the regulation o f insulin and wortmannin.
Examples o f some o f the resulting genes that were regulated are included with their
respective GenBank accession numbers.
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Figure 3.4. Verification o f the up-regulation o f Dream by insulin analyzed by RT-PCR.
Dream was detected at a base level in the control sample. There was an increase in
Dream in the insulin treated sample. RT-PCR was also carried out in the absence o f
DNA as a control which showed no expression. DILK is shown as a control, and is
equally expressed in all lanes shown as the inverse picture o f the gel.

66

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3.4

Ladder Control Insulin

No DNA

Dream

DILK

67

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DISCUSSION
Cell signaling involves a complex network o f interactions that culminate in the nucleus
resulting in changes in gene expression. These changes may be a reflection o f the
morphological and physiological changes o f the cell. Microarray experiments determine
changes in a cell at the transcriptional level and are set up to provide a high level o f
validity. Chips are reciprocally labeled to ensure that dye incorporation is not skewed
by the samples, thereby resulting in any bias o f the results. Subsequently, software is
used that incorporates many levels o f filtering and normalization methods that further
eliminate any irrelevant or misleading information. In this experiment, data elements
were cDNA signals representing gene expression ratios (Cheng et al., 2003).
Calculation o f relative similarity is based on distances between data points. If two genes
have similar expression profiles across the various treatments, the distance between
them will be “small.” On the other hand, if two genes have dissimilar profiles across the
different treatments, the distance between them will be “large.” These distances are
represented by a dendogram or “tree”. Interpretation o f the dendogram allows for
extraction o f relevant biological data. The initial scanned images are the primary
indication that the microarray experiment is successful, and provide a visual basis for
determination o f regulated genes (Figure 3.1). The consistent detection o f a similar
pattern o f hybridization on duplicate spots in a reciprocal fashion, increases the validity
o f the presence o f the particular transcript and hence, the confidence in the output results.
However, the scanned images provide no quantitative data and are therefore not useful
for obtaining quantitative gene expression data. Upon filtering, normalizing, and
clustering the data (Figure 3.2), these visual results are converted to quantitative results
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based on the ratio Log 2, a representation o f the ratio between experimental and control
gene intensities expressed in a log scale o f 2. Therefore, a value o f log 2 =1 represents a
2.0 fold higher expression o f the gene in chemically treated cells as compared to control
cells.

From our results, we determined that 1151 genes were regulated by insulin and/or
wortmannin, with at least a two fold change in gene expression, a great reduction from
the initial 96000 data points (Figure 3.3). However, this number still seems high, and
can be explained by direct and indirect effects o f insulin in cells. Direct stimulation
results in the regulation o f genes that we expect to observe, while indirect stimulation
may result in the regulation o f numerous genes that are not yet known to be regulated
directly or indirectly by insulin. Additionally, we only used one concentration o f insulin
in this study. Likely lower insulin concentrations, or altered treatment times, will be
more specific activators or repressors o f gene transcription and help in data reduction.
The complexity o f cell signaling also lends itself to the high gene numbers. Regulation
o f one gene may knowingly or inadvertingly regulate another due to the intricate and
numerous associations between cell signaling pathways.

Browsing the resultant gene list, we extracted two genes, Dream and Tau, due to interest
and relevance to our study. We determined from the microarray results that Dream was
up-regulated by insulin. RT-PCR was performed and confirmed that Dream is up
regulated in response to the insulin treatment (Figure 3.4). Dream (downstream
regulatory element antagonistic modulator) plays a critical role in pain modulation as a
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transcriptional repressor (Cheng et al., 2002). Insulin regulation o f Dream is novel and
the significance remains to be determined. Recently, some studies have looked at the
regulation o f sensory neurons in diabetes and the mechanism by which these neurons
respond to insulin deficiencies (Calcutt et al., 2004, Toth et al., 2004). While Dream has
not been linked to diabetes directly, its involvement in other neurodegenerative disorders
and its regulation by insulin may suggest a possible role in the regulation o f diabetes. It
should be noted that the RT-PCR was not quantitative and therefore, the increase in
expression o f Dream has not yet been determined. In the future, it would be
advantageous to perform quantitative RT-PCR and also validate the data with Northern
blot analysis.

Experiments are currently underway to verify the regulation o f Tau. Our microarray
experiments illustrated down-regulation o f Tau in response to insulin and up-regulation
in response to the PI3’K specific inhibitor, wortmannin. Tau has been shown to interact
with GSK-3, and is thus very interesting to our study. A splice variant o f GSK-3 p,
GSK-3P2, was identified that contains a 13-residue insert in the kinase domain and has
reduced activity to Tau, a microtubule-associated protein (Mukai et al., 2002). In
addition, a proline-rich tyrosine kinase 2 (PYK2) may be responsible for GSK-3 tyrosine
phosphorylation which, due to transient increases in intracellular calcium, subsequently
increases the phosphorylation o f Tau (Hartigan and Johnson, 1999, Hartigan et al., 2001).
Characterization o f the Drosophila Tau homolog (Heidary and Fortini, 2001) showed a
high degree o f conservation between the human and fly proteins and as a result, the fly
model system will likely serve to provide insight into neuronal integrity and the
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consequences o f the loss o f this integrity in human diseases, such as Alzheimer’s disease.
Tau has been implicated in Alzheimer’s disease which is a neurodegenerative disease
characterized by the accumulation o f P-amyloid and its own hyperphosphorylation
(reviewed in Alvarez et al., 2002). Previous work shows that lithium inhibits Tau
hyperphosphorylation and protects cultured neurons from cell death due to P-amyloid
(Alvarez et al., 1999). Lithium is a known GSK-3 inhibitor, so it is likely that GSK-3
plays a role in the progression o f Alzheimer’s disease. From our results, we can
therefore speculate that insulin and wortmannin could also regulate the phosphorylation
o f Tau through the regulation o f GSK-3. In addition we show that they both affect the
transcription o f Tau. This has implications in therapeutics as insulin and wortmannin, in
addition to lithium, could be used in therapeutic trials to test their ability to ameliorate
neurodegeneration in Alzheimer’s disease. Our studies therefore illustrate regulation o f
Tau at the transcriptional level which provides another dimension to the regulation of
Tau at the post-translational level, as determined by the aforementioned studies. In a
separate experiment, it was shown that Tau over-expression combined with
phosphorylation by Shaggy exacerbated any neurodegeneration as a result o f Tau over
expression (Jackson et al., 2002). In addition, manipulation o f other wingless signaling
molecules downstream o f Shaggy, resulted in the modulation o f neurodegeneration
induced by Tau in vivo (Jackson et al., 2002). Therefore, it is possible to speculate that
insulin regulates the hyperphosphorylation o f Tau through GSK-3, resulting in the
regulation o f Alzheimer’s’ Disease, as well as regulating the transcription o f Tau,
through yet unknown mechanisms (Figure 3.5).
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F ig u re 3.5 - Schematic of Tau regulation illustrating the mechanism of
GSK-3 regulation of Tau protein levels in Alzheimer’s Disease and insulin
regulation of Tau transcription, for which the mechanism has yet to be
determined.

It is evident from our study that microarrays provide an important means to look at the
regulation of gene expression on a global scale in Drosophila S2 cells. Initial gene lists
can be condensed through further filtering and clustering, to include only those genes that
are specifically regulated, and from this focused list, genes of interest or relevance can be
selected and verified. We determined that Dream was up-regulated by insulin, for which
further interpretation of its relevance in pain modulation and cell survival needs to be
explored. In the future, further studies for the Tau gene will verify our findings and
provide more insight into the mechanism of the regulation of Tau by GSK-3.
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CHAPTER FO UR
Directions for Future Study

In the present study, our goal was to further characterize Drosophila ILK both in vitro
and in vivo. In addition, we hoped to identify genes that were regulated by different
treatments using microarray methodology. These studies generated the following
findings which were summarized in greater detail in chapters two and three:
1. Drosophila ILK encodes a conserved protein containing the three
characteristic domains; ankyrin repeats, PH and kinase catalytic domains.
2. Drosophila ILK is phosphorylated in vivo and this phosphorylation is
increased by insulin, in a PI3’K dependent manner.
3. Drosophila ILK is able to phosphorylate PKB/Akt in vitro in a PI3’K
dependent manner, demonstrating increased phosphorylation in response to
insulin, which is inhibited by wortmannin.
4. This phosphorylation o f PKB by DILK occurs at serine 505, the Drosophila
homologue o f the mammalian serine 473 phosphorylation site, in vivo.
5. FPLC fractionated Drosophila ILK is able to phosphorylate substrate PKBGST in vitro.
6. Insulin and wortmannin, PI3’K specific inducer and inhibitor respectively,
illustrate regulation o f numerous genes as was determined by microarray
analysis.
7. Two genes o f interest, Dream shown to be up-regulated by insulin, and Tau
shown to be down-regulated by insulin and up-regulated by wortmannin,
were identified from the resultant microarray gene list. The up-regulation o f
Dream was further confirmed by RT-PCR.

FUTURE PR O SPEC TS

Although the findings o f the present studies have further characterized Drosophila ILK
and determined genes that are regulated by insulin and wortmannin, several key
experiments must still be performed to further validate our findings. The focus o f this
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thesis was to further characterize Drosophila ILK and carry out experiments that would
solidify our hypothesis that DILK is a PDK-2 molecule. While our studies included an
in vitro kinase assay that illustrated the ability o f endogenous DILK from Drosophila S2
cells to phosphorylate substrate PKB, an in vitro kinase assay using bacterially
expressed GST-DILK fusion protein still remains to be done. Bacterially isolated DILK
illustrates that phosphorylation by DILK is in fact attributed to DILK, and not to some
other protein bound in the S2 cells. I purified DILK-GST fusion protein from bacterial
D.coli (BL-21) cells and completion o f a kinase assay will further illustrate that DILK is
able to phosphorylate substrate PKB in vitro.

The ability o f DILK to act in the Wnt/Wg pathway and regulate effector molecules of
that pathway is also very important, when considering the cross regulation o f Wnt/Wg
and PI3’K pathways. Our studies show that DILK is able to phosphorylate
Shaggy/GSK-3, which correlates with mammalian findings (Delcommenne et al., 1998).
However, there are numerous other molecules in the Wnt/Wg pathway that may also be
regulated by DILK. Unpublished work from our lab determined that DILK and Dsh are
able to interact, and that DILK is able to phosphorylate Dsh in vivo. Dishevelled
deletion mutations determined that DILK and Dsh interact in the DEP domain o f Dsh.
Drosophila ILK deletion mutations must be created to determine the region o f DILK
that interacts with Dsh (Figure 4.1). Primers were made for the deletion o f each main
region o f DILK (Table 4.1).
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Z7-ILK Deletion Mutations

a) Wild-type D-ILK

PH D o m ain

3 Ankyrin-like R ep eats

Kinase Domain

b) Delete Ankyrin Repeats

c) Delete PH Domain

d) Delete Kinase Domain

Figure 4.1. Schematic illustrating the domains of DILK deleted via PCR to create DILK
deletion mutations for subsequent determination of the interaction of DILK with Dsh.

Table 4.1. PCR primers for the deletion of the ankyrin, PH and kinase domains of
Drosophila ILK

5’ Primer
3’ Primer

5’ Primer

3’ Primer

5’ Primer

3’ Primer

D IL K A nkyrin Deletions
5'Ecor-l Ank
5 ’CCGG A ATTC ATGGGCC A AGCC A AGCTTGTG3 ’
3 ’ Xho-l
5” TCACTCGAGGCGGCGCATCTTCTCCAGAATGGGAAC3’
D IL K P H Deletions
5 ’ Ecor-l
5’GGAATTCATGGAGGACATATTCCACTGGTGCCGC3’
5 ’ Pst-1
5 ’AAACTGC AGGACGC A ATCCCACTCCATTT AGCG 3 ’
3 ' Pst-1
5 ’GCATTGGTTCTGCAGTTTGGCGTGGCCCTCTTT AGC3 ’
3 ' Xho-l
5’TCACTCG AGGCGGCGCATCTTCTCC AGAATGGGAAC3 ’
D IL K Kinase Deletions
5" Ecor-l
5 ’GGAATTCATGGAGGAC AT ATTCCACTGGTGCCGC3 ’
5' Pst-1
5 ’A A ACTGC AGCTTGTAG AA AAGAGCGGC
3’ Pst-1
3’GCATTGGTTCTGCAGTTTGGCGTTCACACGCGAACC
3’ Xho-l
5” TCACTCGAGGCGGCGCATCTTCTCCAGAATGGGAAC3’
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The amplification o f selected domains was carried out by PCR and verified. The deleted
regions must now be ligated back together and sub-cloned into pAC 5.1 A vector for
subsequent transfection, and expression in Drosophila S2 cells. Coimmunoprecipitation with a Dsh specific antibody will pull down Dsh, and a subsequent
immunoblot against DILK will illustrate regions o f DILK that bind to Dsh. Currently,
primers were only designed for the deletion o f the three important domains o f DILK; the
ankyrin, PH and kinase catalytic domains. After initial determination o f the overall
region that is responsible for binding to Dsh, further work should be carried out to
pinpoint the actual amino acid residue(s) responsible for binding.

Microarray experiments were carried out to evaluate the effects o f insulin and
wortmannin on nuclear gene expression using Drosophila S2 cells. Additional
microarray experiments such as transfected DILK wt versus DILK kd (E359K mutant),
or the effects o f insulin, pervanadate and wortmannin together, will determine the
regulation o f other Drosophila genes. In addition, the experiment with insulin and
wortmannin created a gene list o f 1151 genes that were shown to be regulated by these
treatments. In the future, this gene list could be further explored for data reduction using
other filtering methods, and some candidate genes could be chosen. I initially chose
Dream and Tau as candidate genes. Northern blot analysis or RT-PCR still needs to be
completed to verify the microarray results obtained for Tau. Tau is a very exciting gene
due to its involvement in Alzheimer’s disease and its relation to GSK-3. Mutations in
presenilin 1 (PS1), which binds directly to, and regulates the phosphorylation o f Tau, as
well as GSK-3, as a Tau kinase, suggests that PS1 may regulate the interaction o f Tau
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with GSK-3B. It has been proposed that the increased association o f GSK-3(3 with
mutant PS1 leads to increased phosphorylation o f Tau (Takashima, 1998).

Finally, some experiments in this thesis were carried out using endogenous DILK
immunoprecipitated with a polyclonal DILK antibody. Each o f these experiments was
also attempted with transfected DILK wild-type or kinase dead (E359K mutant).
However, transfection efficiency was a problem for some o f the experiments. Therefore,
completion o f studies using transfected DILK will further verify the ability o f DILK to
act as a kinase. Transfections allow for the use o f DILK wt and DILK kd (E359K
mutant), which offer another dimension to these studies. DILK kd (E359K mutant) acts
as a dominant negative molecule and its use in future studies will demonstrate the effects
o f kinase deficient DILK.

Unpublished work from our lab illustrates other aspects o f DILK characterization. Work
in this thesis illustrates additional experiments that help complete the characterization of
DILK. However, some work still can be done to further show that DILK is indeed a
kinase responsible for the phosphorylation o f the main effector molecules in both the
PI3’K and Wnt/Wg pathways. Knockout studies and siRNA interference in mammalian
systems demonstrated an essential role for ILK in the regulation o f both PKB and GSK3 (Troussard et al., 2003). Similar experiments may be done in Drosophila to further
demonstrate the essential role o f DILK in the regulation o f these effector molecules. In
addition, experiments such as tryptic mapping or mass spectrometry will lead the
researcher into more exciting areas o f research and offer further evidence to support the
findings in this paper.
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